UNITÉ DE RECHERCHE
UMR S 1068
Centre de Recherche en Cancérologie de Marseille
DIRECTEUR : BORG Jean-Paul
ADRESSE : Centre de Recherche en Cancérologie de Marseille
Inserm U1068 – CNRS 7258
27 Bd Leï Roure
CS 30059
13273 MARSEILLE CEDEX 09
TELEPHONE : 04 86 97 72 00
COURRIEL : [email protected]
SITE WEB : http://crcm.marseille.inserm.fr/
RATTACHEMENTS : AMU - INSERM - CNRS - IPC
POLES HOSPITALIERS : Institut Paoli Calmettes
ECOLE DOCTORALE : Sciences de la Vie et de la Santé (ED 062)
DISCIPLINES D’APPARTENANCES : DS 5 - Biologie, Médecine, Santé
SPECIALITÉS : Oncologie/Immunologie
GESTIONNAIRES DE L’UNITÉ : Claude ROUX / Laurence DUVIVIER
EFFECTIFS
Enseignants-Chercheurs :
21
Chercheurs :
55
Autres Enseignants-Chercheurs et Chercheurs :
35
BIATSS/ITA :
51
Autres BIATSS/ITA :
55
Doctorants :
70
Unité de Recherche. Centre de Recherche en Cancérologie de Marseille (CRCM)
Mis à jour : janvier 2017
1/38
EFFECTIFS AFFINÉS
Enseignants-Chercheurs : 21







MCU :
MCU-PH :
MCU-PH :
PU :
PU :
PU-PH :
PU Emérite
Rattachement/Tutelle
4
3
1
1
1
10
:1
Autre Composante
Médecine
Autre Composante
Médecine
Autre Composante
Médecine
Autre Composante
1
17
20
8
8
:2
ABSCIENCES
CNRS
INSERM
CNRS
INSERM
INSERM CNRS
Chercheurs : 55






CR :
CR :
CR :
DR :
DR :
DR Emérite
Autres Enseignants-Chercheurs et Chercheurs : 35


PH : 6
POST-DOCTORANT : 29
BIATSS/ITA : 51











AJT :
TCH :
TCH :
AI :
AI :
AI :
IE :
IE :
IR :
IR :
IR :
3
1
13
1
2
6
3
10
2
3
8
INSERM
CNRS
INSERM
AMU
CNRS
INSERM
CNRS
INSERM
AMU
CNRS
INSERM
Autres BIATSS/ITA : 55

















CAE :
AJT CDD :
AJTP CDD :
TCH CDD :
TCH :
TCH :
TCH CDD :
IE CDD :
IE CDD :
IE CDD :
IR CDD :
IR CDD :
IR :
Ing CDD :
Ing :
Ing CDD :
Cadre :
Doctorants :
1
1
1
1
17
1
3
2
8
1
2
6
3
1
1
1
5
INSERM
CNRS
INSERM
INSERM
IPC
ABSCIENCES
IPC
CNRS
INSERM
PROTISVALOR
CNRS
INSERM
IPC
AMU
IPC
IPC
IPC
70
Unité de Recherche. Centre de Recherche en Cancérologie de Marseille (CRCM)
Mis à jour : janvier 2017
2/38
PERSONNELS IMPLIQUÉS DANS LA RECHERCHE
Nom
Prénom
Statut
Téléphone
Abdou Mohamed
Abouelazz
Aboukhater
Acquaviva
Adélaïde
Adjuto
Aguilera
Agavnian
Ahmad
Aimard
Amouric
Aragnol
Arbiol
Ariey-Bonnet
Arnoulet
Audebert
Aurrand-Lions
Azario
Azzoni
Baccini
Badache
Bailly
Bailly
Balzano
Ballester
Bapin
Barbarat
Bardin
Barea
Barral
Barraud Blanc
Barthet
Basse
Baty
Baudelet
Beloribi Djefaflia
Benmansour
Bertucci
Betzi
Bian
Bidaut
Bigonnet
Bintz
Birnbaum
Blaise
Blanchet
Blaszczak
Blazquez Roman
Blin
Bomane
Borg
Borge
Nehlly
Omar
Charbel
Claire
José
Marjorie
Paula
Emilie
Fahmida
Adrien
Agnès
Denise
Christine
Jérémy
Christine
Stéphane
Michel
Françine
Violette
Michel
Ali
Anne-Laure
Éric
Marielle
Pedro
Luc
Bernadette
Florence
Dolorès
Karine
Marine
Marc
Marie Jeanne
Daniel
Émilie
Sadia
Fatiha
François
Stéphane
Benjamin
Ghislain
Martin
Jennifer
Daniel
Didier
Marine
Ewa
Juan Luis
Marion
Alexandra
Jean-Paul
Laurence
CAE Inserm
Doctorant
Doctorant
CR1 Inserm
TCH IPC
Doctorante
Doctorante
TCH IPC
Doctorante
Doctorant
IR Inserm CDD
PU
AI CNRS
Doctorant
PH IPC
IR IPC
CR1 Inserm
Tech IPC
Doctorant
TCH Inserm
DR2 Inserm
Doctorant
CR1 Inserm
Doctorante
CR1 Inserm
TCH Inserm
TCH IPC
AI Inserm
TCH Inserm
CR1 CNRS
MCU AP-HM
PU-PH
AI CNRS
DR1 CNRS
AI Inserm
Post-Doc
IE AMU CDD
PU-PH
CR2 CNRS
Post-Doc
IR2 AMU
IE Inserm CDD
IE Inserm CDD
DR Inserm
PU-PH
Doctorante
Post-Doc
Doctorant
Post-Doc
Doctorante
PU-PH
AI Inserm
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
91
86
86
86
91
91
86
91
86
86
86
86
86
91
91
91
86
91
91
86
86
86
86
86
86
86
86
86
91
91
91
91
91
91
91
91
91
91
86
91
86
91
91
91
91
86
86
86
86
86
86
91
82
97
97
97
22
82
97
22
97
97
97
97
97
22
22
22
97
22
22
97
97
97
97
97
97
97
97
97
82
82
82
82
16
82
22
82
82
22
97
82
97
82
82
22
22
97
97
97
97
97
97
82
88
72
72
72
33
88
74
33
72
72
72
72
72
36
33
33
72
33
33
72
73
72
72
72
72
73
73
72
88
55
88
88
45
88
33
88
55
47
73
88
73
88
88
33
36
72
72
72
73
72
72
88
12
71
00
62
04
05
03
33
00
00
00
00
00
04
76
07 ou 33 39
91
33
33
08
21
93
57
93
63
61
46
92
28
81
28
03
06
23
07
06
81
79
33
28
01
28
27
54
44
00
00
72
72
00
51
16
Unité de Recherche. Centre de Recherche en Cancérologie de Marseille (CRCM)
Mis à jour : janvier 2017
3/38
Borrello
Bouchacourt
Bouguenina
Bourgeas
Bourras
Bou Tayeh
Boutchama
Boyer
Brenet
Bressy
Bricker
Brunel
Cabaud
Calmels
Camoin
Capel
Carbuccia
Carrier
Cartier-Michaud
Castellano
Castro-Cruz
Cervera
Chabannon
Chaffanet
Chames
Chanez
Charafe-Jauffret
Chaves De Lima
Cherif
Chetrit
Chevrier
Chrabaszcz
Chraa
Chretien
Churikov
Cisa
Cohen
Colazet
Collette
Collignon
Combes
Coppin
Corda
Coulier
Coulon
Courtier
Cresci
Da Costa
Dang
Daulat
David
Defaye
De Grandis
De la Roche Saint André
De Melo
Maria Teresa
Benjamin
Habib
Raphaël
Sarah
Berna
Henri
Jean-Baptiste
Fabienne
Christian
Mickael
Jean-Michel
Olivier
Boris
Luc
Arnaud
Nadine
Alice
Amandine
Rémy
Monica Del
Carmen
Nathalie
Christian
Max
Patrick
Brice
Emmanuelle
Daniel
Chaima
Bernard
Véronique
Elodie
Dounia
Anne-Sophie
Dmitri
Sabina
Romy
Magali
Yves
Aude
Sébastien
Émilie
Yves
François
Stéphane
Frédéric
Marina
Quentin
Cao Cuong
Avais
Guido
Arnaud
Maria
Christophe
Abi
Post-Doc
Doctorant
Doctorant
Doctorant
TCH IPC CDD
Doctorante
TCH Inserm
IE Inserm CDD
CR1 Inserm
Post-Doc CDD
AJT Inserm
CR1 CNRS
IE Inserm
PH IPC
IR Inserm
TCH Inserm
AI Inserm
CR1 CNRS
Post-Doc
IR IPC
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
86
86
86
91
86
86
86
91
86
91
86
86
86
91
86
86
91
91
86
86
97
97
97
16
97
97
97
22
97
82
97
13
97
22
97
97
22
82
97
97
72
72
73
41
72
72
73
33
72
88
73
68
72
34
72
73
34
88
72
73
82
93
21
28
76
00
61 ou 73 65
07
82
15
61 ou 73 65
30
64
41
58
62
08
29
93
32
Doctorante
TCH IPC
PU
Cadre IPC
CR1 CNRS
Doctorant
PU-PH
Doctorant
Doctorante
IE CNRS
IR1 Inserm
Doctorant
Doctorante
Post-Doc
Ing IPC CDD
Doctorant
Doctorant
Doctorant
DR2 Inserm
Doctorante
MCU AMU
Doctorant
CR1 CNRS
CR1 Inserm
CR1 CNRS
Doctorant
IE Inserm CDD
THQ IPC CDD
Post-Doc
Post-Doc
PU Emérite
IR Inserm CDD
Post-Doc
CR1 CNRS
Doctorant
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
86
91
91
91
91
86
91
86
86
86
86
86
86
86
86
86
91
91
86
91
91
86
86
86
86
91
91
86
86
86
86
91
86
86
86
97
22
22
22
82
97
22
97
97
97
97
97
97
97
97
97
82
82
97
82
28
97
97
97
97
22
82
97
97
97
97
82
97
97
97
72
33
34
34
88
72
35
72
72
72
72
72
72
73
72
72
88
88
73
88
82
72
72
72
72
41
88
73
72
72
72
88
72
72
73
00
04
41
77
33
00
09
00
66
07
64
00
71
41
00
85
33
34
31
00
91
74
00
07
00
21
33
03
00
55
51
33
93
00
92
Unité de Recherche. Centre de Recherche en Cancérologie de Marseille (CRCM)
Mis à jour : janvier 2017
4/38
De Sepulveda
Del Bano
Degos
Dehe
Derviaux
Ding
Drivet
Dubreuil
Duprez
Dusetti
Duvivier
Egea
El Kaoutari
Fares
Farina
Fauriat
Fenaux
Ferrier
Finetti
Forand
Foucher
Fourquet
Fraisier
Fuchs
Fujii
Gaillard
Gall
Garcia
Garcia
Garciaz
Garcin
Garnier
Garzino
Gayet
Géli
Gelsi-Boyer
Ghossoub
Gibier
Ginestier
Gonçalvès
Gondois-Rey
Goubard
Gouirand
Gon
Granjeaud
Grenier
Gros
Guasch
GuenneauPuvirajesinghe
Guerrin-Paillet
Guervilly
Guillaumond
Guille
Guittard
Hirsch
Paulo
Joanie
Clara
Pierre-Marie
Carine
Ling
Elsa
Patrice
Estelle
Nelson
Laurence
Antonio
Samad
Joanna
Anne
Cyril
Gregory
Valérie
Pascal
Yona
Etienne
Patrick
Christophe
Robert
Shingo
Pierre-Henri
Sophie
Stéphane
Valérie
Sylvain
Edwige
Séverine
Patrick
Odile
Vincent
Véronique
Rania
Patrick
Christophe
Anthony
Françoise
Armelle
Victoire
Stéphanie
Samuel
Julien
Abigaëlle
Géraldine
CR1 Inserm
Doctorant
Post-Doc
CR1 Inserm
Doctorant
Doctorante
Doctorant
DR1 Inserm
DR2 CNRS
DR2 Inserm
AI Inserm
Post-Doc
IE Inserm CDD
Post-Doc
IE Protisvalor CDD
CR2 Inserm
IE Inserm CDD
Cadre IPC
TCH IPC
IE Inserm CDD
Post-Doc
IR CNRS
Post-Doc
DR Emérite
CR1 CNRS
DR2 CNRS
IE Inserm
PU-PH
CR1 CNRS
Doctorant
Post-Doc
Ing IPC
TCH Inserm
IE Inserm
DR1 CNRS
MCU-PH
IR AMU CDI
IE Inserm
CR1 Inserm
PU-PH
IR2 Inserm
TCH IPC CDD
Doctorante
CR1 CNRS
IR1 Inserm
Doctorant
IE Inserm CDD
CR1 Inserm
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
86
91
86
86
86
91
86
86
86
91
86
86
86
86
86
86
86
91
91
86
86
91
91
86
86
86
91
91
86
86
86
91
86
91
86
91
86
86
91
91
86
86
91
86
86
86
91
86
97
82
97
97
97
82
97
97
97
82
97
97
97
97
97
97
97
22
22
97
97
22
82
97
97
97
82
82
97
97
97
22
97
82
97
22
97
97
22
22
97
97
82
97
97
97
22
97
72
88
73
72
73
88
73
72
73
88
72
72
73
73
72
73
72
33
33
72
72
33
88
72
72
72
87
88
74
73
73
33
73
88
72
41
73
73
35
33
72
73
88
73
73
72
35
72
85
34
41
00
31
29
31
81
11
28
04
53
03
52
00
47
82
52
04
82
72
07
28
00
00
00
05
22
12
12
92
33
62
27
00
75
52
62
09
11
76
32
06
91
01
93
09
00
Tania
Mathilde
Jean-Hugues
Fabienne
Arnaud
Geoffrey
Ivan
Post-Doc
Doctorant
CR2 Inserm
CR2 Inserm
04
04
04
04
04
04
04
86
86
86
91
91
86
86
97
97
97
82
22
97
97
72
72
72
88
33
72
72
55
00
00
06
04
74
71
TCH IPC
Post-Doc
DR2 Emérite
Unité de Recherche. Centre de Recherche en Cancérologie de Marseille (CRCM)
Mis à jour : janvier 2017
5/38
Hoffer
Houvenaeghel
Hubert
Imjeti
Iovanna
Isnardon
Isogawa
Josselin
Jourquin
Jover
Just-Landi
Khan
Karaki
Kashyap
Kerfelec
Koubi
Lac
Lachaud
Ladaique
Lan
Laloum
Lambaudie
Launay
Laureti
Leblanc
Leca
Lecocq
Legrand
Legrand
Lembo
Lequeue
Létard
Lhoumeau
Livrati
Llorente
Loncle
Lopez Almeida
Lopez
Lopez
Lopez
Lopresti
Luciano
Machu
Maestroni
Mailhac
Malenfant
Malissen
Mallet
Mamessier
Manai
Mancini
Mangon
Marchetto
Maroc
Martinez
Marty
Laurent
Gilles
Lucas
Naga Sailaja
Juan
Daniel
Asako
Emmanuelle
Frédéric
Sylvie
Sylvaine
Muntaz
Sara
Rudra
Brigitte
Myriam
Sophie
Christophe
Amandine
Wenjun
Laurence
Eric
Hélène
Luisa
Raphaël
Julie
Éric
Annaelle
Sylvain
Frédérique
Charlotte
Sébastien
Anne-Catherine
Philippe
Bertrand
Céline
Léonor
Isabelle
Marc
Sophie
Alexia
Pierre
Christophe
Laetitia
Camille
Carine
Nausicaa
Françoise
Emilie
Marwa
Stéphane
Aurélie
Sylvie
Christine
Sébastien
Jean-Baptiste
Post-Doc
PU-PH
IR Inserm CDD
Post-Doc
DR1 Inserm
Cadre IPC
IR CNRS
IE Inserm
IE CNRS
TCH CNRS
TCH IPC
Post-Doc
Doctorante
Post-Doc
CR1 CNRS
Doctorant
IE Inserm CDD
CR1 CNRS
Doctorante
Doctorante
TCH Inserm
PH IPC
IR CNRS CDD
Post-Doc
Post-Doc
Doctorant
TCH Inserm
TCH Inserm CDD
Doctorant
TCH IPC CDD
Doctorante
TCH ABSciences
MCU-PH
TCH IPC
DR2 CNRS
IR IPC
Doctorante
AJT CNRS CDD
IR Inserm
IR Inserm
Doctorante
CR1 CNRS
IE CNRS CDD
IR CNRS CDD
Doctorant
TCH IPC
Doctorante
TCH IPC
CR1 Inserm
Doctorant
CR1 Inserm
Doctorant
IR2 Inserm
TCH IPC
Doctorant
TCH IPC CDD
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
86
91
91
86
91
86
86
86
86
86
86
86
86
86
91
86
91
86
86
91
86
91
86
86
86
91
86
86
86
86
86
86
86
86
86
91
86
86
86
86
86
86
86
86
91
91
86
86
91
91
86
86
86
91
86
86
97
22
82
97
82
97
97
97
97
97
97
97
97
97
82
97
82
97
97
82
97
22
97
97
97
82
97
97
97
97
97
97
97
97
97
82
97
97
97
97
97
97
97
97
82
22
97
97
22
22
97
97
97
22
97
97
73
33
88
73
88
73
72
72
72
72
73
72
72
73
88
73
88
73
72
88
72
33
72
73
73
88
72
72
74
73
72
72
72
73
72
88
72
73
72
72
72
72
74
72
88
34
72
73
33
33
72
73
72
33
72
73
35
33
34
52
03
64
00
63
00
03
45
00
66
52
33
12
15
82
00
27
02
33
00
81
52
36
84
82
11
52
72
82
54
45
00
15
53
61
61
83
00
00
05
00
34
46
00
44
33
33
91
21
53
33
52
52
Unité de Recherche. Centre de Recherche en Cancérologie de Marseille (CRCM)
Mis à jour : janvier 2017
6/38
Maslowska
Masoud
Matmati
Maurin
Maya-Milles
Mejias Laguna
Menck
Meyer
Milhas
Minguet
Modesti
Molejon
Montersino
Morelli
Morin
Mosca
Mozziconacci
Muller
Murati
Nguyen
Nguyen
Nigri
Nino Suarez
Normanno
Novoa Del Toro
Nunès
Olive
Olivier
Orlanducci
Orsoni
Pages
Pasero
Pasquier
Pastor
Pelletier
Péon Lopez
Philippin
Platet
Pophillat
Poplineau
Préau
Raux
Raynaud
Rebuffet
Receveur-Bréchot
Restouin
Rey
Richaud
Rocchi
Roche
Rochigneux
Rodriguez-Granveaux
Roques
Roux
Rovere-Reiss
Rozotte
Katarzyna
Rawand
Samah
Pauline
Douglas
Raquel
Kerstin
Damien
Sabine
Christopher
Mauro
Maria Inès
Camille
Xavier
Stéphanie
Cyndie
Marie-Joëlle
Christophe
Anne
Dang Tan
Lia
Jérémy
Carlos
Davide
Elva
Jacques
Daniel
Bruno
Florence
Jean-Christophe
Vincent
Christine
Eddy
Sonia
Jeoffrey
Antonio
Gaëlle
Nadine
Matthieu
Mathilde
Véronique
Brigitt
Adeline
Etienne
Véronique
Audrey
Jérôme
Manon
Palma
Philippe
Philippe
Magda
Julie
Claude
Julie
Cyril
Post-Doc
Post-Doc
Doctorante
Doctorant
Post-Doc
Post-Doc
Post-Doc
IR Inserm CDD
Doctorante
IE CNRS CDD
DR2 CNRS
Post-Doc
Ing AMU CDD
DR2 CNRS
Doctorante
IE Inserm CDD
PH IPC
Cadre IPC
PH IPC
Doctorant
IE Inserm CDD
Doctorant
Post-Doc
IR2 CNRS
Doctorante
DR2 Inserm
PU PH
ATP2 Inserm
TCH IPC
TCH Inserm
CR1 CNRS
Post-Doc
CR1 CNRS
IE Inserm
Doctorant
Post-Doc
IE CNRS
IR2 Inserm
IE Inserm
Post-Doc
TCH Inserm
Doctorant
Doctorante
CR ABSciences
DR2 CNRS
TCH IPC
PH IPC
Cadre IPC
CR1 Inserm
CR1 CNRS
Doctorant
IE Inserm
TCH Inserm
IE Inserm
TCH IPC
AJTP Inserm CDD
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
86
91
86
86
86
91
86
91
86
86
86
91
86
86
86
86
91
91
91
86
86
91
86
86
86
86
86
91
86
86
86
86
91
86
86
86
86
86
86
86
91
86
91
91
91
86
91
86
86
91
86
86
91
86
86
86
97
82
97
97
97
22
97
82
97
97
97
82
97
97
97
97
22
22
22
97
97
82
97
97
97
97
97
82
97
97
97
97
22
97
97
97
97
97
97
97
82
97
82
22
16
97
22
97
97
16
97
97
82
97
97
97
72
88
72
72
72
33
72
88
72
73
72
88
73
73
73
72
33
33
41
72
73
88
72
73
72
72
72
88
73
73
72
73
34
72
72
74
72
73
72
73
88
73
88
34
45
73
33
73
72
45
72
73
88
72
72
73
00
29
00
53
00
33
00
34
00
05
00
00
32
31
74
84
77
33
75
00
22
15
00
91
00
74
71
29
44
62
00
47
06
76
93
21
00
12
59
12
00
33
34
06
01
32
33
63
67
06
00
69
06
05
01
62
Unité de Recherche. Centre de Recherche en Cancérologie de Marseille (CRCM)
Mis à jour : janvier 2017
7/38
Rubis
Saccone
Saez Ayala
Salaun
Santofina
Santoni
Sari
Scaglione
Sebbagh
Semenchenko
Sergé
Simon
Sonongbua
Soubeyran
Soucie
Spoto
Swayden
Tadi
Taha
Taieb
Takedachi
Tasmadjian
Tassin de Nonneville
Termine
Thibult
Thuault
Tisserand
Toiron
Tomasini
Tournaire
Valdenaire
Vandevelde
Van Hiel
Vasseur
Verdier-Pinard
Vernerey
Vey
Viens
Voitovich
Wagner
Walton
Wicinski
Xerri
Zhang
Zhang
Zidi
Zimmermann
Marion
Marjorie
Magali
Danièle
Patricia
Marie-Josée
Karim
Sarah
Michaël
Kostyantyn
Arnauld
Marie-Noëlle
Ying
Philippe
Erinn
Patricia
Mirna
Satish
Mohammed
David
Arato
Fabienne
Alexandre
Elise
Marie-Laure
Sylvie
Julie
Yves
Richard
Roselyne
Simon
Amelle
Boris
Sophie
Pascal
Julien
Norbert
Patrice
Iuliia
Monica
Alexandra
Julien
Luc
Hongshan
Xu
Bochra
Pascale
AI AMU
Doctorante
IR Inserm CDD
AI Inserm
Post-Doc
CR1 CNRS
TCH Inserm
AI CNRS
CR1 Inserm
Post-Doc
MCU-PH
DR2 CNRS
Doctorant
CR1 Inserm
CR1 Inserm
TCH Inserm
Doctorante
Post-Doc
Doctorant
MCU-PH
Post-Doc
AJTP Inserm
Doctorant
IE2 Inserm
Cadre IPC
MCU AMU
Doctorant
TCH IPC
CR1 Inserm
MCU AMU
Doctorant
Doctorante
Doctorant
CR1 Inserm
CR1 Inserm
IR Inserm CDD
PU-PH
PU-PH
Doctorante
Doctorante
Doctorante
TCH IPC
PU-PH
Doctorant
Doctorant
Doctorante
DR2 Inserm
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
04
00
04
04
04
04
04
04
04
04
04
04
04
04
04
04
86
91
86
86
91
86
91
86
86
86
86
86
86
91
86
91
91
86
86
86
86
86
86
91
86
86
86
86
91
91
86
86
00
91
86
86
91
91
86
86
86
91
91
86
86
86
86
97
82
97
97
82
97
82
97
97
97
97
97
97
82
97
82
82
97
97
97
97
97
97
82
97
97
97
97
82
82
97
97
00
82
97
97
22
22
13
97
97
22
22
97
97
97
97
72
88
72
73
88
72
88
72
72
72
72
72
73
88
72
88
88
73
72
72
72
72
73
88
73
73
72
72
88
88
72
73
00
88
73
73
37
37
68
72
72
34
34
72
72
72
73
93
05
00
21
29
56
29
00
57
52
92
00
40
07
83
29
07
92
00
67
00
10
05
33
63
22
83
53
15
05
00
12
00
06
21
12
54
78
30
00
00
08
57
00
66
00
51
Unité de Recherche. Centre de Recherche en Cancérologie de Marseille (CRCM)
Mis à jour : janvier 2017
8/38
PERSONNELS AVEC HDR
Nom
Aragnol
Aurrand-Lions
Ballester
Badache
Barthet
Baty
Bertucci
Birnbaum
Blaise
Borg
Brunel
Calmels
Camoin
Carrier
Chabannon
Chaffanet
Chames
Charafe-Jauffret
Collette
Coulier
Coulon
De la Roche Saint André
De Sepulveda
Dubreuil
Duprez
Dusetti
Fuchs
Gaillard
Garcia
Géli
Gonçalvès
Guasch
Hirsch
Houvenaegel
Iovanna
Kerfelec
Llorente
Lopez
Mancini
Modesti
Mozziconacci
Nunès
Olive
Pagès
Receveur-Brechot
Rocchi
Roche
Santoni
Simon
Soubeyran
Soucie
Taieb
Tomasini
Prénom
Denise
Michel
Pedro
Ali
Marc
Daniel
François
Daniel
Didier
Jean-Paul
Jean-Michel
Boris
Luc
Alice
Christian
Max
Patrick
Emmanuelle
Yves
François
Stéphane
Christophe
Paulo
Patrice
Estelle
Nelson
Robert
Pierre-Henri
Stéphane
Vincent
Anthony
Géraldine
Ivan
Gilles
Juan
Brigitte
Bertrand
Marc
Stéphane
Mauro
Marie-Joëlle
Jacques
Daniel
Vincent
Véronique
Palma
Philippe
Marie-Josée
Marie-Noëlle
Philippe
Erinn
David
Richard
Statut
PU
CR1 Inserm
CR1 Inserm
DR2 Inserm
PU-PH
DR1 CNRS
PU-PH
DRE Inserm
MD – PU-PH
PU-PH
CR1 CNRS
PH IPC
IRE Inserm
CR1 CNRS
PU
Cadre IPC
CR1 CNRS
PU-PH
DR2 Inserm
CR1 Inserm
CR1 CNRS
CR1 CNRS
CR1 Inserm
DR1 Inserm
DR2 CNRS
DR2 Inserm
DRCE CNRS
DR2 CNRS
PH-PU
DR1 CNRS
PH
CR1 Inserm
DR2 Inserm
PU-PH
DR1 Inserm
CR1 CNRS
CR1 CNRS
IRE Inserm
CR1 Inserm
DR2 CNRS
PH
DR2 Inserm
PU-PH
CR1 CNRS
DR2 CNRS
CR1 Inserm
CR1 CNRS
CR1 CNRS
CR1 CNRS
CR1 Inserm
CR1 Inserm
MCU-PH
CR1 Inserm
Unité de Recherche. Centre de Recherche en Cancérologie de Marseille (CRCM)
Mis à jour : janvier 2017
9/38
Tournaire
Verdier-Pinard
Vey
Viens
Xerri
Zimmermann
Roselyne
Pascal
Norbert
Patrice
Luc
Pascale
MCU
CR1 Inserm
PU-PH
PU-PH
PU-PH
DR2 Inserm
EQUIPES DE RECHERCHE ET THEMATIQUES
EQUIPE : E1 - Molecular Oncology
RESPONSABLE : BIRNBAUM Daniel
EQUIPE : E2 - Cell Polarity, Signaling and Cancer
RESPONSABLE : BORG Jean-Paul
EQUIPE : E3 - Signaling, Hematopoiesis and Mechanism of Oncogenesis
RESPONSABLE : DUBREUIL Patrice
EQUIPE : E4 - Molecular Mechanisms of Tumor Cell Migration
RESPONSABLE : BADACHE Ali
EQUIPE : E5 - Junctional Adhesion Molecules in Tumour/host Interactions
RESPONSABLE : AURRAND-LIONS Michel
EQUIPE : E6 - Epigenetic Factors in Normal and Malignant Hematopoiesis
RESPONSABLE : DUPREZ Estelle
EQUIPE : E7 - Spatio-Temporal Regulation of Cell Signaling - Scaffolds & Phosphoinositides
RESPONSABLE : ZIMMERMANN Pascale
EQUIPE : E8 - Cell stress
RESPONSABLE : IOVANNA Juan
EQUIPE : E9 - DNA Damage Tolerance
RESPONSABLE : PAGES Vincent
EQUIPE : E10 - Telomeres and Chromatin
RESPONSABLE : GELI Vincent
EQUIPE : E11 - Homologous Recombination, NHEJ and Maintenance of Genomic Integrity
RESPONSABLE : MODESTI Mauro
EQUIPE : E12 - Structure-Specific Endonucleases and Genome Stability
RESPONSABLE : GAILLARD Pierre-Henri
EQUIPE : E13 - Genome Dynamics and Recombination
RESPONSABLE : LLORENTE Bertrand
EQUIPE : E14 - Immunity & Cancer
RESPONSABLE : OLIVE Daniel
EQUIPE : E15 - Integrative Structural & Chemical Biology
RESPONSABLES : COLLETTE Yves & MORELLI Xavier
EQUIPE : E16 - Antibody Therapeutics & Immunotargeting
RESPONSABLES : BATY Daniel & CHAMES Patrick
EQUIPE : E17 - Computational Biology & Drug Design
RESPONSABLE : BALLESTER Pedro
EQUIPE ATIP AVENIR CNRS: Lésions de l’ADN par pontage inter-brin et maladies du sang
RESPONSABLE : Christophe LACHAUD
Unité de Recherche. Centre de Recherche en Cancérologie de Marseille (CRCM)
Mis à jour : janvier 2017
10/38
PERSONNELS PAR EQUIPE DE RECHERCHE
EQUIPE : E1 - Molecular Oncology
RESPONSABLE : BIRNBAUM Daniel
Acquaviva
Adélaïde
Aimard
Azzoni
Bertucci
Birnbaum
Cabaud
Carbuccia
Cervera
Chaffanet
Charafe-Jauffret
Cherif
Chevrier
Collignon
Courtier
Finetti
Garnier
Gelsi-Boyer
Ginestier
Gros
Guasch
Guille
Houvenaeghel
Josselin
Karaki
Lambaudie
Launay
Lopez
Lopresti
Mamessier
Manaï
Mejias Laguna
Mozziconacci
Murati
Nguyen
Rocchi
Taieb
Valdenaire
Viens
Wicinski
Claire
José
Adrien
Violette
François
Daniel
Olivier
Nadine
Nathalie
Max
Emmanuelle
Chaima
Véronique
Aude
Frédéric
Pascal
Séverine
Véronique
Christophe
Abigaëlle
Géraldine
Arnaud
Gilles
Emmanuelle
Sara
Eric
Simon
Marc
Alexia
Emilie
Marwa
Raquel
Marie-Joëlle
Anne
Dang Tan
Palma
David
Simon
Patrice
Julien
EQUIPE : E2 - Cell Polarity, Signaling and Cancer
RESPONSABLE : BORG Jean-Paul
Bailly
Borg
Boyer
Daulat
Fourquet
Gonçalvès
Guenneau-Puvirajesinghe
Guerrin-Paillet
Éric
Jean-Paul
Jean-Baptiste
Avais
Patrick
Anthony
Tania
Mathilde
Unité de Recherche. Centre de Recherche en Cancérologie de Marseille (CRCM)
Mis à jour : janvier 2017
11/38
Ladaique
Lhoumeau
Lopez Almeida
Marchetto
Martinez
Maurin
Santoni
Sebbagh
Semenchenko
Toiron
Wagner
Walton
Audebert
Baudelet
Camoin
Pophillat
Amandine
Anne-Catherine
Léonor
Sylvie
Sébastien
Pauline
Marie-Josée
Michaël
Kostyantyn
Yves
Monica
Alexandra
Stéphane
Émilie
Luc
Matthieu
EQUIPE : E3 - Signaling, Hematopoiesis and Mechanism of Oncogenesis
RESPONSABLE : DUBREUIL Patrice
Borrello
Brenet
Cisa
De Sepulveda
Dubreuil
Fénaux
Forand
Lecocq
Legrand
Létard
Lopez
Mosca
Soucie
Tisserand
Maria Teresa
Fabienne
Sabina
Paulo
Patrice
Grégory
Yona
Éric
Annaëlle
Sébastien
Sophie
Cyndie
Erinn
Julie
EQUIPE : E4 - Molecular Mechanisms of Tumor Cell Migration
RESPONSABLE : BADACHE Ali
Badache
Bouguenina
Chanez
Mangon
Nguyen
Salaun
Thuault
Verdier-Pinard
Ali
Habib
Brice
Aurélie
Lia
Danièle
Sylvie
Pascal
EQUIPE : E5 - Junctional Adhesion Molecules in Tumour/host Interactions
RESPONSABLE : AURRAND-LIONS Michel
Aurrand-Lions
Balzano
Bardin
Bailly
Bouchacourt
Michel
Marielle
Florence
Anne-Laure
Benjamin
Unité de Recherche. Centre de Recherche en Cancérologie de Marseille (CRCM)
Mis à jour : janvier 2017
12/38
Cartier-Michaud
De Grandis
Grenier
Mancini
Pelletier
Rubis
Sergé
Amandine
Maria
Julien
Stéphane
Jeoffrey
Marion
Arnauld
EQUIPE : E6 - Epigenetic Factors in Normal and Malignant Hematopoiesis
RESPONSABLE : DUPREZ Estelle
Calmels
Chabannon
Duprez
Garciaz
Koubi
Platet
Poplineau
Vandevelve
Vernerey
Zidi
Boris
Christian
Estelle
Sylvain
Myriam
Nadine
Mathilde
Amelle
Julien
Bochra
EQUIPE : E7 - Spatio-Temporal Regulation of Cell Signaling - Scaffolds & Phosphoinositides
RESPONSABLE : ZIMMERMANN Pascale
Castro-Cruz
David
Egea
Fares
Ghossoub
Kashyap
Imjeti
Leblanc
Lembo
Menck
Van Hiel
Zimmermann
Monica Del Carmen
Guido
Antonio
Joanna
Rania
Rudra
Naga Sailaja
Raphaël
Frédérique
Kerstin
Boris
Pascale
EQUIPE : E8 - Cell stress
RESPONSABLE : IOVANNA Juan
Abdou Mohamed
Adjuto
Barea
Barraud Blanc
Barthet
Beloribi Djefaflia
Bian
Bigonnet
Bintz
Borge
Bressy
Carrier
Ding
Dusetti
Fraisier
Garcia
Nehlly
Marjorie
Dolorès
Marine
Marc
Sadia
Benjamin
Martin
Jennifer
Laurence
Christian
Alice
Ling
Nelson
Christophe
Stéphane
Unité de Recherche. Centre de Recherche en Cancérologie de Marseille (CRCM)
Mis à jour : janvier 2017
13/38
Gayet
Gouirand
Guillaumond
Iovanna
Lac
Lan
Leca
Loncle
Masoud
Molejon
Nigri
Olivier
Roques
Saccone
Santofina
Sari
Soubeyran
Spoto
Swayden
Tomasini
Tournaire
Vasseur
Odile
Victoire
Fabienne
Juan
Sophie
Wenjun
Julie
Céline
Rawand
Maria Inès
Jérémy
Bruno
Julie
Marjorie
Patricia
Karim
Philippe
Patricia
Mirna
Richard
Roselyne
Sophie
EQUIPE : E9 - DNA Damage Tolerance
RESPONSABLE : PAGES Vincent
Chrabaszcz
Fuchs
Fujii
Isogawa
Laureti
Maslowska
Pages
Philippin
Elodie
Robert
Shingo
Asako
Luisa
Katarzyna
Vincent
Gaelle
EQUIPE : E10 - Telomeres and Chromatin
RESPONSABLE : GELI Vincent
Aguilera
Aragnol
Churikov
Corda
Coulon
De la Roche Saint André
Géli
Jourquin
Luciano
Machu
Maestroni
Matmati
Maya-Milles
Minguet
Nino Suarez
Simon
Tassin De Nonneville
Paula
Denise
Dmitri
Yves
Stéphane
Christophe
Vincent
Frédéric
Pierre
Christophe
Laetitia
Samah
Douglas
Christopher
Carlos
Marie-Noëlle
Alexandre
Unité de Recherche. Centre de Recherche en Cancérologie de Marseille (CRCM)
Mis à jour : janvier 2017
14/38
EQUIPE : E11 - Homologous Recombination, NHEJ and Maintenance of Genomic Integrity
RESPONSABLE : MODESTI Mauro
Chaves De Lima
De Melo
Garcin
Gon
Modesti
Normanno
Tadi
Zhang
Daniel
Abi
Edwige
Stéphanie
Mauro
Davide
Satish
Hongshan
EQUIPE : E12 - Structure-Specific Endonucleases and Genome Stability
RESPONSABLE : GAILLARD Pierre-Henri
Blaszczak
Blin
Dehe
Gaillard
Guervilly
Scaglione
Takedachi
Ewa
Marion
Pierre-Marie
Pierre-Henri
Jean-Hugues
Sarah
Arato
EQUIPE : E13 - Genome Dynamics and Recombination
RESPONSABLE : LLORENTE Bertrand
Arbiol
Garcia
Khan
Legrand
Llorente
Christine
Valérie
Muntaz
Sylvain
Bertrand
EQUIPE : E14 - Immunity & Cancer
RESPONSABLE : OLIVE Daniel
Abouelazz
Aboukhater
Arnoulet
Barbarat
Blaise
Blazquez-Roman
Bourras
Bou Tayeh
Chraa
Chretien
Coppin
Degos
Fauriat
Foucher
Gondois-Rey
Guittard
Hirsch
Just-Landi
Lequeue
Livrati
Malissen
Mallet
Morin
Omar
Charbel
Christine
Bernadette
Didier
Juan-Luis
Sarah
Berna
Dounia
Anne-Sophie
Émilie
Clara
Cyril
Etienne
Françoise
Geoffrey
Ivan
Sylvaine
Charlotte
Philippe
Nausicaa
Françoise
Stéphanie
Unité de Recherche. Centre de Recherche en Cancérologie de Marseille (CRCM)
Mis à jour : janvier 2017
15/38
Nunès
Olive
Orlanducci
Pasero
Pastor
Rey
Rochigneux
Sonongbua
Taha
Vey
Xerri
Jacques
Daniel
Florence
Christine
Sonia
Jérôme
Philippe
Ying
Mohammed
Norbert
Luc
EQUIPE : E15 - Integrative Structural & Chemical Biology
RESPONSABLES : COLLETTE Yves & MORELLI Xavier
Amouric
Ariey-Bonnet
Barral
Basse
Benmansour
Betzi
Blanchet
Bourgeas
Brunel
Castellano
Chetrit
Collette
Combes
Derviaux
Drivet
Goubard
Hoffer
Milhas
Montersino
Morelli
Muller
Pasquier
Raux
Rebuffet
Receveur-Bréchot
Restouin
Roche
Saez Ayala
Voitovich
Zhang
Agnès
Jérémy
Karine
Marie jeanne
Fatiha
Stéphane
Marine
Raphaël
Jean Michel
Rémy
Bernard
Yves
Sébastien
Carine
Elsa
Armelle
Laurent
Sabine
Camille
Xavier
Christophe
Eddy
Brigitt
Etienne
Véronique
Audrey
Philippe
Magali
Iuliia
Xu
EQUIPE : E16 - Antibody Therapeutics & Immunotargeting
RESPONSABLES : BATY Daniel & CHAMES Patrick
Baty
Chames
Cohen
Colazet
Cresci
Defaye
Del Bano
Hubert
Daniel
Patrick
Romy
Magali
Marina
Arnaud
Joanie
Lucas
Unité de Recherche. Centre de Recherche en Cancérologie de Marseille (CRCM)
Mis à jour : janvier 2017
16/38
Kerfelec
Mailhac
Meyer
Raynaud
Termine
Brigitte
Camille
Damien
Adeline
Elise
EQUIPE : E17 - Computational Biology & Drug Design
RESPONSABLE : Pedro BALLESTER
Ahmad
Ballester
Bomane
Dang
Novoa Del Toro
Peon Lopez
Fahmida
Pedro
Alexandre
Cuong Cao
Elva
Antonio
EQUIPE ATIP AVENIR CNRS: Lésions de l’ADN par pontage inter-brin et maladies du sang
RESPONSABLE : Christophe LACHAUD
LACHAUD Christophe
EQUIPE : E18 – SERVICES COMMUNS
Agavnian
Emilie
Azario
Francine
Baccini
Michel
Bapin
Luc
Bidaut
Ghislain
Boutchama
Henri
Bricker
Mickael
Capel
Arnaud
Coulier
François
Da Costa
Quentin
Duvivier
Laurence
El Kaoutari
Samad
Farina
Anne
Ferrier
Valerie
Gall
Sophie
Garzino
Patrick
Granjeaud
Samuel
Gibier
Patrick
Isnardon
Daniel
Jover
Sylvie
Laloum
Laurence
Lopez
Isabelle
Malenfant
Carine
Maroc
Christine
Marty
Jean-Baptiste
Orsoni
Jean-Christophe
Préau
Véronique
Richaud
Manon
Rodriguez-Granveaux Magda
Roux
Claude
Rovere-Reiss
Julie
Rozotte
Cyril
Unité de Recherche. Centre de Recherche en Cancérologie de Marseille (CRCM)
Mis à jour : janvier 2017
17/38
Tasmadjian
Fabienne
Thibult
Marie-Laure
ACCUEIL MASTERS
Master Pathologie Humaine – Oncologie : 17
Master Développement et Immunologie : 3
Master Bioinformatique, Biochimie Structurale et Génomique : 2
Master Pathologie Humaine - Génétique Humaine et Médicale : 1
Master Biologie Moléculaire et Cellulaire : 1
Master Immunologie : 1
Master Génie Biologique : 1
Master Biosciences : 1
THESES DE DOCTORAT ANNÉE 2015
AOUAR Besma
AUDRY Julien
BENYAMINE Audrey
COPPIN Emilie
EL HELOU Rita
KOUBI Myriam
LE Suong
Altération de la production
d'interféron de Type I par les
Cellules Plasmacytoïdes
Dendritiques: ciblage de la
voie de signalisation BCR-Like
Réplication et maintenance des
télomères chez S. Pombe : rôle
du complexe RPA dans la
prévention ou la résolution de
structures secondaires de type
G-quadruplexes
Ciblage de BTN3A en
immunothérapie anti-tumorale
basée sur les Lymphocytes T
Vg9Vd2. Application aux
Leucémies aiguës Myéloïdes et
au cancer du pancréas
Leucémie myélomonocytaire
chronique : rôle des protéines
Dok-1 et Dok-2 en tant que
suppresseurs de tumeur
Rôle des programmes
épigénétiques dans la
régulation de l'identité des
cellules souches cancéreuses
mammaires
PLZF et les protéines du
groupe Polycomb : interaction
et implications dans
l'hématopoïétique normale et
pathologique
Caractérisation phénotypique
et fonctionnelle des
lymphocytes T infiltrants dans
les lymphomes B humains
28/09/2015
24/04/2015
20/05/2015
06/02/2015
25/09/2015
17/12/2015
30/04/2015
Unité de Recherche. Centre de Recherche en Cancérologie de Marseille (CRCM)
Mis à jour : janvier 2017
18/38
Elaboration de nouvelles
stratégies d’immunothérapie
dans les leucémies aigües.
Etude de l’effet
immunomodulateur des IMiDs
sur la réponse NK dans la
leucémie aigüe myéloïde
Etude de la reprogrammation
métabolique de
l'adénocarcinome canalaire
pancréatique
LEROY Aude
OLIVARES Oriane
15/06/2015
08/01/2015
CONTRATS ANNÉE 2015
Nature
Organisme
Année
Responsable
Titre
Fondation
ARC
2015
AURRAND-LIONS
Inhibition of
adhesion molecule
expression in
lymphoma by
protein/protein
interaction inhibitors
targeting the golgi
machinery
Fondation
AMU, Amidex,
emergence
2015
ZIMMERMANN
PDZ Targeting hits
cancer
communication
Unité de Recherche. Centre de Recherche en Cancérologie de Marseille (CRCM)
Mis à jour : janvier 2017
19/38
Régional
PACA Region
2015
Régulation de la
survie et du
développement des
Leucémies Aiguës
MANCINI/Pelletier
Lymphoblastiques
de type B par le
microenvironnement
de la moelle osseuse
Caritatif
GEFLUC
2015
Ali Badache
Multiparametric
analysis of tumor
cell motility driven
by a microfluidic
platform
National
IbiSa
2015
Baty D
Nanobodies platform
Baty D
Nanovector:
Development of
nanobody-based
vectors that cross
the blood brain
barrier via receptormediated
transcytosis for
brain delivery of
imaging or
therapeutic agents
National
ANR
2015
Unité de Recherche. Centre de Recherche en Cancérologie de Marseille (CRCM)
Mis à jour : janvier 2017
20/38
National
ANR
2015
Chames P
NanoGluAct: Acting
on the
glutamatergic
synapse with
nanobodies
caritatif
Gefluc
2015
Kerfelec B
Développement de
modèles multicellulaires
tridimensionnels
pour évaluer
l'activité antitumorale d'anticorps
bispécifiques Fablike dans les cancers
du sein échappant à
l'action du
trastuzumab
Fondation
A*MIDEX
Interdisciplinarity
2015
Tania
Puvirajesinghe
BIOCLOACK
Role of the MINK1PRICKLE1 complex
in the tumorigenic
program
Role of MINK1 in the
tumorigenic
program
Fondation
Fondation ARC
2015
Jean-Paul
Borg/Avais Daulat
Caritatif
GEFLUC Marseille
2015
Jean-Paul
Borg/Avais Daulat
Unité de Recherche. Centre de Recherche en Cancérologie de Marseille (CRCM)
Mis à jour : janvier 2017
21/38
National
Projet Libre
Biologie INCa
2015
Jean-Paul Borg
Molecular study and
targeting of the
WNT/PCP VANGL2
receptor in breast
cancer
Industriel
VIRBAC
mars-15
BRUNEL
Nouveaux dérivés
d’acides biliaires
antimicrobiens
National
ANR Blanche
oct-15
MORELLI
Innovating Strategy
to modulate ProteinProtein Interaction
Caritatif
GEFLUCPediatrie
sept-15
PASQUIER
Novel therapeutic
targets in
neuroblastoma
2015
P de Sepulveda
(leader)
Implication des
kinases FES dans la
transformation
cellulaire
F Brenet (Leader)
Aspects
épigénétiques et
métaboliques de la
coopération
oncogéniques dans
les pathologies
tumorales
dépendantes de cKIT.
Fondation
Régional
ARC Projet
Canceropole
PACA
2015
Unité de Recherche. Centre de Recherche en Cancérologie de Marseille (CRCM)
Mis à jour : janvier 2017
22/38
226 k€ (salaire
post-doc inclus)
Molecular and
Functional
relationship between
transcription and
epigenetic factors in
leukemogenesis
National
INCa-PLBio
janv-15
GUILLOUF
(équipe Duprez=
équipe
partenaire)
Industriel
INSERMTRANSFERT
nov-15
DUPREZ
140 k€ (salaire IR
inclus) EPILAM
Juan Iovanna
La protéine de
stress Nupr1 est
nécessaire pour le
développement du
cancer du pancréas.
Etude de son
mécanisme d’action.
Juan Iovanna
Rôle des cellules
exprimant Dclk1
dans l’initiation et la
progression des
tumeurs intestinales
et pancréatiques
Caritatif
National
LNCC
INCa/PLBio
2015
2015
Unité de Recherche. Centre de Recherche en Cancérologie de Marseille (CRCM)
Mis à jour : janvier 2017
23/38
National
INCa/PLBio
PHC Utique /
Campus France
2015
2015
Sophie Vasseur
La cachexie associée
au cancer
pancréatique :
étude de la
connexion entre la
reprogrammation
métabolique
tumorale,
l’inflammation et le
transport de
metabolites
Alice Carrier
Nouvelle méthode
de diagnostic du
cancer prostatique
par dosage
immunologique de
TP53INP1: mise en
œuvre in vivo et in
vitro et application
en physiopathologie
humaine
Unité de Recherche. Centre de Recherche en Cancérologie de Marseille (CRCM)
Mis à jour : janvier 2017
24/38
Régional
Caritatif
Cancéropôle
PACA
GEFLUC
2015
2015
Alice Carrier
Mesure du
fonctionnement
mitochondrial dans
les cellules
cancéreuses et de
leur microenvironnement :
applications
fondamentales et
cliniques
Alice Carrier
Mesure du
fonctionnement
mitochondrial dans
les cellules
cancéreuses et de
leur microenvironnement :
applications
fondamentales et
cliniques
Unité de Recherche. Centre de Recherche en Cancérologie de Marseille (CRCM)
Mis à jour : janvier 2017
25/38
Fondation
Fondation pour
la Recherche
Médicale
2015
Alice Carrier
Décryptage des
dysfonctionnements
du métabolisme
énergétique dans les
cellules cancéreuses
pancréatiques en
vue de les cibler en
thérapie
Européen
UE COST
2015
Patrizia
Agostinis/Juan
Iovanna
Autophagy
Canceropole
PACA
02/12/2015
NUNES
AML_CyTOF,
towards Immunoprofiling of AML
patients by mass
cytometry
Régional
Canceropole
PACA / SIRIC
02/12/2015
FAURIAT
NK cells and AML
mouse models
Caritatif
LNCC
janv-15
Pascale
ZIMMERMANN
Syntenin, a novel
target to counteract
cancer progression.
Unité de Recherche. Centre de Recherche en Cancérologie de Marseille (CRCM)
Mis à jour : janvier 2017
26/38
Fondation
Caritatif
ARC
janv-15
GEFLUC
Fondation
ARC
Industriel
Genosciences
Pharma
nov-15
nov-15
mars-15
Pascale
ZIMMERMANN
Relevance of
syntenin exosomes
in cancer and
tumormicroenvironment
signaling
C. Ginestier
Targeting breast
cancer stem cells
with nanoparticles
through miR600/Wnt epigenetic
signaling blockade
G. GuaschGrangeon
Regulation of cancer
stem cell from
transition zone
tumors by their
niche
C. Ginestier
Evaluating the effect
of GNS 03-08
compound on the
breast CSC
BREVETS ANNÉE 2015
Daniel Olive. Anticorps immuno-modulateurs ciblant de nouveaux membres de la famille
des BTN (demande de dépôt). AMU, IPC.
ANTIBODIES DIRECTED AGAINST ICOS FOR TREATING GRAFT-VERSUS-HOST DISEASE
Application number: 20150239978
Abstract: The invention relates to a specific antibody directed against, for use for treating graft
versus host disease.
Type: Application
Filed: September 3, 2013
Issued: August 27, 2015
Inventors: Gilles Marodon, Daniel Olive, Christine Menetrier-Caux
BTLA Antibodies and Uses Thereof
Unité de Recherche. Centre de Recherche en Cancérologie de Marseille (CRCM)
Mis à jour : janvier 2017
27/38
Application number: 20150147344
Abstract: The invention relates to BTLA antibodies that block BTLA-HVEM interaction and uses
thereof.
Type: Application
Filed: November 21, 2014
Issued: May 28, 2015
Inventor: Daniel Olive
Combination of a ligand of HVEM and an immunotoxin for use in therapy
Europe EP 13306037.6 19/07/2013
Filed: 18 Juil. 2014 PCT/EP2014/065512
Issued : 22 Janv. 2015 WO2015/007887
Inventor: Daniel Olive
METHODS FOR PREDICTING THE SURVIVAL TIME OF SUBJECTS SUFFERING FROM
MELANOMA METASTASES
EP15306601.4 9 octobre 2015
Inventor: Daniel Olive
Vy9Vo2 T cells-based immunotherapy targeting BTN3A molecules in Acute Myeloid
Leukemia (AML)
Inventor: Daniel Olive
NEW BIOMARKER FOR OUTCOME IN AML PATIENTS
PCT/EP2015/056619 – WO/2015/144841
Filed : 26 Mars 2015
Issued : 01.10.2015
Inventor: Daniel Olive
Anti-PD-L1 immunotoxin for use in therapy
EP 15305511.6 7 avril 2015
Inventor: Daniel Olive
Non-invasive imaging of tumor PD-L1 expression
EP15305510 7 avril 2015
Inventor: Daniel Olive
M Aurrand-Lions:
ANTAGONISTS OF GRASP55 FOR USE AS A MEDICAMENT. EP15306260:
M Aurrand-Lions:
New biomarker for outcome in AML: EP15305471:
J.-P. Borg et al. Brevet EP13305409.8: METHODS AND PHARMACEUTICALS COMPOSITIONS
FOR TREATING BREAST CANCERS.
Aurrand-Lions M: EP15305471.3 US2013309252 (A1)
NEW BIOMARKER FOR OUTCOME IN AML;
Yves Collette: Methods for the treatment of Human Acute Lymphoblastic Leukemia
(application number EP14305419.5
Combination products useful in the diagnostic of latently infected Mycobacterium
Tuberculosis. Juan Iovanna
Method, Kit ad phenotyping for phenotyping pancreatic ductal adenocarcinoma behavior
by transcriptomics. Juan Iovanna
Surexpression de la Ménine dans les tumeurs malignes de la prostate.
Inventor: Palma Rocchi
Xanthine derivative inhibitors of BET proteins. PCT 2015, EP15307163.4.
Inventor: Xavier Morelli
Anti-NKG2D single domain antibodies and uses thereof. Baty D, Chames P, Kerfelec B,
Termine E
Unité de Recherche. Centre de Recherche en Cancérologie de Marseille (CRCM)
Mis à jour : janvier 2017
28/38
Anti-mGluR2 conformational single domain antibodies and uses thereof. Pin JP, Mathis G,
Baty D, Rondard P, Scholler P, Nevoltris D, Chames P
Protein constructs designed for targeting and lysis of cells. Cohen JHM, Mahmoud W, Libyh
MT, Godin N, Gimenez A, Tabary T, Donvito B, Baty D, Dervillez X
PUBLICATIONS ANNÉE 2015
Acharya,P., Luongo, T. S., Georgiev, I. S., Matz, J., Schmidt, S. D., Louder, M. K., Kessler,
P., Yang, Y., McKee, K., O'Dell, S., Chen, L., Baty, D., Chames, P., Martin, L., Mascola, J. R.,
and Kwong, P. D. Correction for Acharya et al., Heavy Chain-Only IgG2b Llama Antibody Effects
Near-Pan HIV-1 Neutralization by Recognizing a CD4-Induced Epitope That Includes Elements of
Coreceptor- and CD4-Binding Sites. J Virol. 2015; 89:883-885.
Alagha,K., Secq, V., Pahus, L., Sofalvi, T., Palot, A., Bourdin, A., and Chanez, P. We Should
Prohibit Warfarin in Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2015; 191:958-960.
Alomairi,J., Bonacci, T., Ghigo, E., and Soubeyran, P. Alterations of host cell ubiquitination
machinery by pathogenic bacteria. Front Cell Infect Microbiol. 2015; 5:17Ambrosi,N., Arrosagaray, V., Guerrieri, D., Uva, P. D., Petroni, J., Herrera, M. B., Iovanna,
J. L., Leon, L., Incardona, C., Chuluyan, H. E., and Casadei, D. H. alpha-Lipoic Acid Protects
Against Ischemia-Reperfusion Injury in Simultaneous Kidney-Pancreas Transplantation.
Transplantation. 2015;
Archier,A., Heimburger, C., Guerin, C., Morange, I., Palazzo, F. F., Henry, J. F.,
Schneegans, O., Mundler, O., Abdullah, A. E., Sebag, F., Imperiale, A., and Taieb, D. FDOPA PET/CT in the diagnosis and localization of persistent medullary thyroid carcinoma. Eur J Nucl
Med Mol Imaging. 2015;
Arock,M., Sotlar, K., Akin, C., Broesby-Olsen, S., Hoermann, G., Escribano, L., Kristensen,
T. K., Kluin-Nelemans, H. C., Hermine, O., Dubreuil, P., Sperr, W. R., Hartmann, K., Gotlib,
J., Cross, N. C., Haferlach, T., Garcia-Montero, A., Orfao, A., Schwaab, J., Triggiani, M.,
Horny, H. P., Metcalfe, D. D., Reiter, A., and Valent, P. KIT mutation analysis in mast cell
neoplasms: recommendations of the European competence network on mastocytosis. Leukemia.
2015; 29:1223-1232.
Audry,J., Maestroni, L., Delagoutte, E., Gauthier, T., Nakamura, T. M., Gachet, Y.,
Saintome, C., Geli, V., and Coulon, S. RPA prevents G-rich structure formation at lagging-strand
telomeres to allow maintenance of chromosome ends. EMBO J. 2015; 34:1942-1958.
Bakour,S., Garcia, V., Loucif, L., Brunel, J. M., Gharout-Sait, A., Touati, A., and Rolain, J.
M. Rapid identification of carbapenemase-producing Enterobacteriaceae, Pseudomonas aeruginosa
and Acinetobacter baumannii using a modified Carba NP test. New Microbes.New Infect. 2015;
7:89-93.
Baldeck,N., Janel-Bintz, R., Wagner, J., Tissier, A., Fuchs, R. P., Burkovics, P., Haracska,
L., Despras, E., Bichara, M., Chatton, B., and Cordonnier, A. M. FF483-484 motif of human
Poleta mediates its interaction with the POLD2 subunit of Poldelta and contributes to DNA damage
tolerance. Nucleic Acids Res. 2015; 43:2116-2125.
Barbolosi,D., Hapdey, S., Battini, S., Faivre, C., Mancini, J., Pacak, K., Farman-Ara, B., and
Taieb, D. Determination of the unmetabolised F-FDG fraction by using an extension of simplified
kinetic analysis method: clinical evaluation in paragangliomas. Med Biol Eng Comput. 2015;
Barbosa-Sampaio,H.C., Drynda, R., Liu, B., Rodriguez de Ledesma, A. M., Malicet, C.,
Iovanna, J. L., Jones, P. M., Muller, D. S., and Persaud, S. J. Reduced nuclear protein 1
expression improves insulin sensitivity and protects against diet-induced glucose intolerance
through up-regulation of heat shock protein 70. Biochim Biophys Acta. 2015; 1852:962-969.
Barete,S., Lortholary, O., Damaj, G., Hirsch, I., Chandesris, M. O., Elie, C., Hamidou, M.,
Durieu, I., Suarez, F., Grosbois, B., Limal, N., Gyan, E., Larroche, C., Guillet, G., Kahn, J.
E., Casassus, P., Amazzough, K., Coignard-Biehler, H., Georgin-Lavialle, S., Lhermitte, L.,
Unité de Recherche. Centre de Recherche en Cancérologie de Marseille (CRCM)
Mis à jour : janvier 2017
29/38
Fraitag, S., Canioni, D., Dubreuil, P., and Hermine, O. Long-term efficacy and safety of
cladribine (2-CdA) in adult patients with mastocytosis. Blood. 2015; 126:1009-1016.
Bertucci,F., Finetti, P., Colpaert, C., Mamessier, E., Parizel, M., Dirix, L., Viens, P.,
Birnbaum, D., and Van Laere, S. PDL1 expression in inflammatory breast cancer is frequent and
predicts for the pathological response to chemotherapy. Oncotarget. 2015; 6:13506-13519.
Bertucci,F., Finetti, P., and Birnbaum, D. The E2F4 prognostic signature is also predictive of the
pathological response of breast cancer to chemotherapy. Breast Cancer Res. 2015; 17:54Bertucci,F., Finetti, P., Mamessier, E., Pantaleo, M. A., Astolfi, A., Ostrowski, J., and
Birnbaum, D. PDL1 expression is an independent prognostic factor in localized GIST.
Oncoimmunology. 2015; 4:e1002729Bilan,R., Brazhnik, K., Chames, P., Baty, D., Nabiev, I., and Sukhanova, A. Oriented
Conjugates of Single-domain Antibodies and Fluorescent Quantum Dots for Highly Sensitive
Detection of Tumor-associated Biomarkers in Cells and Tissues. Phys Procedia. 2015; 73:228-234.
Boissel,N., Renneville, A., Leguay, T., Cornillet-Lefebvre, P., Recher, C., Lecerf, T.,
Delabesse, E., Berthon, C., Blanchet, O., Prebet, T., Pautas, C., Chevallier, P., Lepretre, S.,
Girault, S., Bonmati, C., Guieze, R., Himberlin, C., Randriamalala, E., Preudhomme, C.,
Jourdan, E., Dombret, H., and Ifrah, N. Dasatinib in high-risk core binding factor acute myeloid
leukemia in first complete remission. A French Acute Myeloid leukemia Intergroup trial.
Haematologica. 2015; 100:780-785.
Bonzi,J., Bornet, O., Betzi, S., Kasper, B. T., Mahal, L. K., Mancini, S. J., Schiff, C., SebbanKreuzer, C., Guerlesquin, F., and Elantak, L. Pre-B cell receptor binding to galectin-1 modifies
galectin-1/carbohydrate affinity to modulate specific galectin-1/glycan lattice interactions. Nat
Commun. 2015; 6:6194Brisson,L. and Carrier, A. A novel actor in antitumoral immunity: The thymus-specific serine
protease TSSP/PRSS16 involved in CD4 T-cell maturation. Oncoimmunology. 2015; 4:e1026536Brisson,L., Pouyet, L., N'Guessan, P., Garcia, S., Lopes, N., Warcollier, G., Iovanna, J. L.,
and Carrier, A. The Thymus-Specific Serine Protease TSSP/PRSS16 Is Crucial for the Antitumoral
Role of CD4+ T Cells. Cell Rep. 2015; 10:39-46.
Cervera,N., Carbuccia, N., Garnier, S., Guille, A., Adelaide, J., Murati, A., Vey, N.,
Mozziconacci, M. J., Chaffanet, M., Birnbaum, D., and Gelsi-Boyer, V. Molecular
characterization of acute erythroid leukemia (M6-AML) usingtargeted next-generation sequencing.
Leukemia. 2015;
Chanez,B., Goncalves, A., Badache, A., and Verdier-Pinard, P. Eribulin targets a ch-TOGdependent directed migration of cancer cells. Oncotarget. 2015;
Coiffard,B., Soubeyran, P., and Ghigo, E. Editorial: Manipulation of the cellular microbicidal
response and endocytic dynamic by pathogens membrane factors. Front Cell Infect Microbiol.
2015; 5:42Collette,Y., Prebet, T., Goubard, A., Adelaide, J., Castellano, R., Carbuccia, N., Garnier, S.,
Guille, A., Arnoulet, C., Charbonier, A., Mozziconacci, M. J., Birnbaum, D., Chaffanet, M.,
and Vey, N. Drug response profiling can predict response to ponatinib in a patient with
t(1;9)(q24;q34)-associated B-cell acute lymphoblastic leukemia. Blood Cancer J. 2015; 5:e292Coppin,E., Malergue, F., Thibult, M. L., Scifo, C., Favre, C., and Nunes, J. A. Flow cytometric
analysis of intracellular phosphoproteins in human monocytes. Cytometry B Clin Cytom. 2015;
Coppin,E., Gelsi-Boyer, V., Morelli, X., Cervera, N., Murati, A., Pandolfi, P. P., Birnbaum,
D., and Nunes, J. A. Mutational analysis of the DOK2 haploinsufficient tumor suppressor gene in
chronic myelomonocytic leukemia (CMML). Leukemia. 2015; 29:500-502.
Coulibaly,O., Thera, M. A., Kone, A. K., Siaka, G., Traore, P., Djimde, A. A., Brunel, J. M.,
Gaudart, J., Piarroux, R., Doumbo, O. K., and Ranque, S. A Double-Blind Randomized Placebo-
Unité de Recherche. Centre de Recherche en Cancérologie de Marseille (CRCM)
Mis à jour : janvier 2017
30/38
Controlled Clinical Trial of Squalamine Ointment for tinea capitis Treatment. Mycopathologia. 2015;
179:187-193.
De Grandis,M., Lhoumeau, A. C., Mancini, S. J., and Aurrand-Lions, M. Adhesion receptors
involved in HSC and early-B cell interactions with bone marrow microenvironment. Cell Mol Life Sci.
2015;
Deplanque,G., Demarchi, M., Hebbar, M., Flynn, P., Melichar, B., Atkins, J., Nowara, E.,
Moye, L., Piquemal, D., Ritter, D., Dubreuil, P., Mansfield, C. D., Acin, Y., Moussy, A.,
Hermine, O., and Hammel, P. A randomized, placebo-controlled phase III trial of masitinib plus
gemcitabine in the treatment of advanced pancreatic cancer. Ann Oncol. 2015; 26:1194-1200.
Devillier,R., Mansat-De Mas, V., Gelsi-Boyer, V., Demur, C., Murati, A., Corre, J., Prebet,
T., Bertoli, S., Brecqueville, M., Arnoulet, C., Recher, C., Vey, N., Mozziconacci, M. J.,
Delabesse, E., and Birnbaum, D. Role of ASXL1 and TP53 mutations in the molecular
classification and prognosis of acute myeloid leukemias with myelodysplasia-related changes.
Oncotarget. 2015; 6:8388-8396.
Duconseil,P., Gilabert, M., Gayet, O., Loncle, C., Moutardier, V., Turrini, O., Calvo, E.,
Ewald, J., Giovannini, M., Gasmi, M., Bories, E., Barthet, M., Ouaissi, M., Goncalves, A.,
Poizat, F., Raoul, J. L., Secq, V., Garcia, S., Viens, P., Iovanna, J., and Dusetti, N.
Transcriptomic Analysis Predicts Survival and Sensitivity to Anticancer Drugs of Patients with a
Pancreatic Adenocarcinoma. Am J Pathol. 2015; 185:1022-1032.
Duluc,C., Moatassim-Billah, S., Chalabi-Dchar, M., Perraud, A., Samain, R., Breibach, F.,
Gayral, M., Cordelier, P., Delisle, M. B., Bousquet-Dubouch, M. P., Tomasini, R., Schmid,
H., Mathonnet, M., Pyronnet, S., Martineau, Y., and Bousquet, C. Pharmacological targeting
of the protein synthesis mTOR/4E-BP1 pathway in cancer-associated fibroblasts abrogates
pancreatic tumour chemoresistance. EMBO Mol Med. 2015;
Fan,Y., Richelme, S., Avazeri, E., Audebert, S., Helmbacher, F., Dono, R., and Maina, F.
Tissue-Specific Gain of RTK Signalling Uncovers Selective Cell Vulnerability during Embryogenesis.
PLoS Genet. 2015; 11:e1005533Fant,B., Samuel, A., Audebert, S., Couzon, A., El Nagar S., Billon, N., and Lamonerie, T.
Comprehensive interactome of Otx2 in the adult mouse neural retina. Genesis. 2015; 53:685-694.
Fardini,Y., Perez-Cervera, Y., Camoin, L., Pagesy, P., Lefebvre, T., and Issad, T. Regulatory
O-GlcNAcylation sites on FoxO1 are yet to be identified. Biochem Biophys Res Commun. 2015;
462:151-158.
Farnault,L., Gertner-Dardenne, J., Gondois-Rey, F., Michel, G., Chambost, H., Hirsch, I.,
and Olive, D. Full but impaired activation of innate immunity effectors and virus-specific T cells
during CMV and EBV disease following cord blood transplantation. Bone Marrow Transplant. 2015;
50:459-462.
Forster,A., Grotha, S. P., Seeger, J. M., Rabenhorst, A., Gehring, M., Raap, U., Letard, S.,
Dubreuil, P., Kashkar, H., Walczak, H., Roers, A., and Hartmann, K. Activation of KIT
modulates the function of TRAIL-R in mast cells. Allergy. 2015; 70:764-774.
Fouqué,A., Delalande, O., Jean, M., Castellano, R., Josselin, E., Malleter, M., Shoji, K.,
Mac, D. H., Rampanarivo, H., Collette, Y., van de Weghe, P., and Legembre, P. A novel
covalent mTOR inhibitor, DHM25, shows in vivo anti-tumor activity against triple-negative breast
cancer cells. J Med Chem. 2015; 58:6559-6573.
Friand,V., David, G., and Zimmermann, P. Syntenin and syndecan in the biogenesis of
exosomes. Biol Cell. 2015; 107:331-341.
Ganesan,A., Debulpaep, M., Wilkinson, H., Van Durme J., De Baets G., Jonckheere, W.,
Ramakers, M., Ivarsson, Y., Zimmermann, P., Van Eldere J., Schymkowitz, J., and
Rousseau, F. Selectivity of Aggregation-Determining Interactions. J Mol Biol. 2015; 427:236-247.
Unité de Recherche. Centre de Recherche en Cancérologie de Marseille (CRCM)
Mis à jour : janvier 2017
31/38
Gayet,O., Loncle, C., Duconseil, P., Gilabert, M., Lopez, M. B., Moutardier, V., Turrini, O.,
Calvo, E., Ewald, J., Giovannini, M., Gasmi, M., Bories, E., Barthet, M., Ouaissi, M.,
Goncalves, A., Poizat, F., Raoul, J. L., Secq, V., Garcia, S., Viens, P., Dusetti, N., and
Iovanna, J. A subgroup of pancreatic adenocarcinoma is sensitive to the 5-aza-dC DNA
methyltransferase inhibitor. Oncotarget. 2015; 6:746-754.
Geli,V. and Lisby, M. Recombinational DNA repair is regulated by compartmentalization of DNA
lesions at the nuclear pore complex. Bioessays. 2015; 37:1287-1292.
Ghidouche,A., Lopez, M., and Olive, D. Roles of Nectin-4 in tumor progression. Ann Oncol.
2015; 26:ii34Grange,M., Giordano, M., Mas, A., Roncagalli, R., Firaguay, G., Nunes, J. A., Ghysdael, J.,
Schmitt-Verhulst, A. M., and Auphan-Anezin, N. Control of CD8 T cell proliferation and
terminal differentiation by active STAT5 and CDKN2A/CDKN2B. Immunology. 2015; 145:543-557.
Guerin,C., Lowery, A., Gabriel, S., Castinetti, F., Philippon, M., Vaillant-Lombard, J.,
Loundou, A., Henry, J. F., Sebag, F., and Taieb, D. Preoperative imaging for focused
parathyroidectomy: Making a good strategy even better. Eur J Endocrinol. 2015; 172:519-526.
Guervilly,J., Takedachi, A., Naim, V., Scaglione, S., Chawhan, C., Lovera, Y., Despras, E.,
Kuraoka, I., Kannouche, P., Rosselli, F., and Gaillard, P. L. The SLX4 Complex Is a SUMO E3
Ligase that Impacts on Replication Stress Outcome and Genome Stability. Mol Cell. 2015; 57:123137.
Guillaumond,F., Bidaut, G., Ouaissi, M., Servais, S., Gouirand, V., Olivares, O., Lac, S.,
Borge, L., Roques, J., Gayet, O., Pinault, M., Guimaraes, C., Nigri, J., Loncle, C., Lavaut, M.
N., Garcia, S., Tailleux, A., Staels, B., Calvo, E., Tomasini, R., Iovanna, J. L., and Vasseur,
S. Cholesterol uptake disruption, in association with chemotherapy, is a promising combined
metabolic therapy for pancreatic adenocarcinoma. Proc Natl Acad Sci U S A. 2015; 112:2473-2478.
Heskamp,S., Hobo, W., Molkenboer-Kuenen, J. D., Olive, D., Oyen, W. J., Dolstra, H., and
Boerman, O. C. Non-invasive imaging of tumor PD-L1 expression using radiolabeled anti-PD-L1
antibodies. Cancer Res. 2015; 75:2928-2936.
Hirsinger,E., Carvalho, J. E., Chevalier, C., Lutfalla, G., Nicolas, J. F., Peyrieras, N., and
Schubert, M. Expression of fluorescent proteins in Branchiostoma lanceolatum by mRNA injection
into unfertilized oocytes. J Vis Exp. 2015; 52042Hu,F., Shi, X., Li, B., Huang, X., Morelli, X., and Shi, N. Structural Basis for the Interaction
between the Golgi Reassembly-Stacking Protein GRASP65 and the Golgi Matrix Protein GM130.
Journal of Biological Chemistry. 2015; 290:2673-2682.
Hultberg,A., Morello, V., Huyghe, L., De Jonge N., Blanchetot, C., Hanssens, V., de Boeck
G., Silence, K., Festjens, E., Heukers, R., Roux, B., Lamballe, F., Ginestier, C., CharafeJauffret, E., Maina, F., Brouckaert, P., Saunders, M., Thibault, A., Dreier, T., De Haard H.,
and Michieli, P. Depleting MET-expressing tumor cells by ADCC provides a therapeutic advantage
over inhibiting HGF/MET signaling. Cancer Res. 2015; 75:3373-3383.
Imperiale,A., Moussallieh, F. M., Roche, P., Battini, S., Cicek, A. E., Sebag, F., Brunaud, L.,
Barlier, A., Elbayed, K., Loundou, A., Bachellier, P., Goichot, B., Stratakis, C. A., Pacak, K.,
Namer, I. J., and Taieb, D. Metabolome Profiling by HRMAS NMR Spectroscopy of
Pheochromocytomas and Paragangliomas Detects SDH Deficiency: Clinical and Pathophysiological
Implications. Neoplasia. 2015; 17:55-65.
Imperiale,A., Battini, S., Averous, G., Mutter, D., Goichot, B., Bachellier, P., Pacak, K.,
Taieb, D., and Namer, I. J. In vivo detection of catecholamines by magnetic resonance
spectroscopy: A potential specific biomarker for the diagnosis of pheochromocytoma. Surgery.
2015;
Iovanna,J. Short-term contracts: Labs leak staff under French law. Nature. 2015; 518:35-
Unité de Recherche. Centre de Recherche en Cancérologie de Marseille (CRCM)
Mis à jour : janvier 2017
32/38
Iovanna,J.L. Impact of molecular biology on the natural history of pancreatic cancer. Rev Prat.
2015; 65:367-369.
Jouffret,L., Turrini, O., Ewald, J., Moutardier, V., Iovanna, J. L., and Delpero, J. R. Longterm survivors after pancreatectomy for cancer: the TNM classification is outdated. ANZ J Surg.
2015; 85:860-864.
Jouve,N., Bachelier, R., Despoix, N., Blin, M. G., Khalili Matinzadeh M., Poitevin, S.,
Aurrand-Lions, M., Fallague, K., Bardin, N., Blot-Chabaud, M., Vely, F., Dignat-George, F.,
and Leroyer, A. S. CD146 mediates VEGF-induced melanoma cell extravasation through FAK
activation. Int J Cancer. 2015; 137:50-60.
Ka,M.B., Bechah, Y., Olive, D., and Mege, J. L. Programmed death ligand-1 expression and
memory T-cell generation in Coxiella burnetii infection. Microb Pathog. 2015; 80C:6Ka,M.B., Gondois-Rey, F., Ghigo, E., Raoult, D., Olive, D., and Mege, J. L. Imbalance of
circulating lymphoid cells in Q fever endocarditis. Pathog Dis. 2015; 73:1-3.
Karaki,S., Andrieu, C., Ziouziou, H., and Rocchi, P. The Eukaryotic Translation Initiation Factor
4E (eIF4E) as a Therapeutic Target for Cancer. Adv Protein Chem Struct Biol. 2015;
Kashyap,R., Roucourt, B., Lembo, F., Fares, J., Carcavilla, A. M., Restouin, A.,
Zimmermann, P., and Ghossoub, R. Syntenin controls migration, growth, proliferation, and cell
cycle progression in cancer cells. Front Pharmacol. 2015; 6:241Katsogiannou,M., Ziouziou, H., Karaki, S., Andrieu, C., de Villeneuve, M. H., and Rocchi, P.
The hallmarks of castration-resistant prostate cancers. Cancer Treat Rev. 2015; 41:588-597.
Kaucka,M., Petersen, J., Janovska, P., Radaszkiewicz, T., Smy Kova L., Daulat, A. M.,
Borg, J. P., Schulte, G., and Bryja, V. Asymmetry of VANGL2 in migrating lymphocytes as a tool
to monitor activity of the mammalian WNT/planar cell polarity pathway. Cell Commun Signal.
2015; 13:2Ke,J., Zhao, Z., Hong, S. H., Bai, S., He, Z., Malik, F., Xu, J., Zhou, L., Chen, W., MartinTrevino, R., Wu, X., Lan, P., Yi, Y., Ginestier, C., Ibarra, I., Shang, L., McDermott, S.,
Luther, T., Clouthier, S. G., Wicha, M. S., and Liu, S. Role of microRNA221 in regulating normal
mammary epithelial hierarchy and breast cancer stem-like cells. Oncotarget. 2015; 6:3709-3721.
Kocic,I., Kowianski, P., Rusiecka, I., Lietzau, G., Mansfield, C., Moussy, A., Hermine, O.,
and Dubreuil, P. Neuroprotective effect of masitinib in rats with postischemic stroke. Naunyn
Schmiedebergs.Arch Pharmacol. 2015; 388:79-86.
Kuhnl,A., Valk, P. J., Sanders, M. A., Ivey, A., Hills, R. K., Mills, K. I., Gale, R. E., Kaiser, M.
F., Dillon, R., Joannides, M., Gilkes, A., Haferlach, T., Schnittger, S., Duprez, E., Linch, D.
C., Delwel, R., Lowenberg, B., Baldus, C. D., Solomon, E., Burnett, A. K., and Grimwade, D.
Down-regulation of the Wnt inhibitor CXXC5 predicts a better prognosis in acute myeloid leukemia.
Blood. 2015; 125:2985-2994.
Leblanc,C., Vilter, H., Fournier, J. B., Delage, L., Potin, P., Rebuffet, E., Michel, G., Solari,
P. L., Feiters, M. C., and Czjzek, M. Vanadium haloperoxidases: from the discovery 30 years ago
to X-Ray crystallographic and V K-edge absorption spectroscopic studies. Coord Chem Rev. 2015;
301-302:134-146.
Lelj-Garolla,B., Kumano, M., Beraldi, E., Nappi, L., Rocchi, P., Ionescu, D. N., Fazli, L.,
Zoubeidi, A., and Gleave, M. E. Hsp27 inhibition with OGX-427 sensitizes non-small cell lung
cancer cells to erlotinib and chemotherapy. Mol Cancer Ther. 2015; 14:1107-1116.
Leonard,P.H., Grzenda, A., Mathison, A., Morbeck, D. E., Fredrickson, J. R., de Assuncao,
T. M., Christensen, T., Salisbury, J., Calvo, E., Iovanna, J., Coddington, C. C., Urrutia, R.,
and Lomberk, G. The Aurora A-HP1gamma pathway regulates gene expression and mitosis in
cells from the sperm lineage. BMC Dev Biol. 2015; 15:23-
Unité de Recherche. Centre de Recherche en Cancérologie de Marseille (CRCM)
Mis à jour : janvier 2017
33/38
Lhoumeau,A.C., Martinez, S., Boher, J. M., Monges, G., Castellano, R., Goubard, A.,
Doremus, M., Poizat, F., Lelong, B., De Chaisemartin, C., Bardin, F., Viens, P., Raoul, J. L.,
Prebet, T., Aurrand-Lions, M., Borg, J. P., and Goncalves, A. Overexpression of the
Promigratory and Prometastatic PTK7 Receptor Is Associated with an Adverse Clinical Outcome in
Colorectal Cancer. PLoS ONE. 2015; 10:e0123768Li,H., Leung, K. S., Wong, M. H., and Ballester, P. J. The Use of Random of Forest to Predict
Binding Affinity in Docking. Bioinformatics and Biomedical Engineering. 2015; 9044:238-247.
Li,H., Leung, K. S., Vong, M. H., and Ballester, P. J. Improving AutoDock Vina Using Random
Forest: The Growing Accuracy of Binding Affinity Prediction by the Effective Exploitation of Larger
Data Sets. Mol Inform. 2015; 34:115-126.
Li,H., Leung, K. S., Wong, M. H., and Ballester, P. J. Low-Quality Structural and Interaction
Data Improves Binding Affinity Prediction via Random Forest. Molecules. 2015; 20:10947-10962.
Ligat,L., Saint-Laurent, N., El-Mrani, A., Gigoux, V., Al Saati, T., Tomasini, R., Nigri, J.,
Dejean, S., Pont, F., Baer, R., Guillermet-Guibert, J., Cordelier, P., Lopez, F., and
Dufresne, M. Pancreatic preneoplastic lesions plasma signatures and biomarkers based on
proteome profiling of mouse models. Br J Cancer. 2015;
Liu,X., Liu, C., Zhou, J., Chen, C., Qu, F., Rossi, J. J., Rocchi, P., and Peng, L. Promoting
siRNA delivery via enhanced cellular uptake using an arginine-decorated amphiphilic dendrimer.
Nanoscale. 2015; 7:3867-3875.
Loncle,C., Bonjoch, L., Folch-Puy, E., Lopez-Millan, M. B., Lac, S., Molejon, M. I.,
Chuluyan, E., Cordelier, P., Dubus, P., Lomberk, G., Urrutia, R., Closa, D., and Iovanna, J.
L. IL-17 functions through the novel REG3beta-JAK2-STAT3 inflammatory pathway to promote the
transition from chronic pancreatitis to pancreatic cancer. Cancer Res. 2015; 75(22):4852-62:48524862.
Lopes,N., Serge, A., Ferrier, P., and Irla, M. Thymic Crosstalk Coordinates Medulla Organization
and T-Cell Tolerance Induction. Front Immunol. 2015; 6:365Lopez,M.B., Garcia, M. N., Grasso, D., Bintz, J., Molejon, M. I., Velez, G., Lomberk, G.,
Neira, J. L., Urrutia, R., and Iovanna, J. Functional Characterization of Nupr1L, a novelp53Regulated Isoform of the High Mobility Group (HMG)-Related Protumoral Protein Nupr1. J Cell
Physiol. 2015; 230:2936-2950.
Luciano,P., Dehe, P. M., Audebert, S., Geli, V., and Corda, Y. Replisome Function During
Replicative Stress Is Modulated by Histone H3 Lysine 56 Acetylation Through Ctf4. Genetics. 2015;
199:1047-1063.
Mancini,S.J., Elantak, L., Boned, A., Espeli, M., Guerlesquin, F., and Schiff, C. Examination
of galectin-induced lattice formation on early B-cell development. Methods Mol Biol. 2015;
1207:169-184.
Martinez,E., Silvy, F., Fina, F., Bartoli, M., Krahn, M., Barlesi, F., Figarella-Branger, D.,
Iovanna, J., Laugier, R., Ouaissi, M., Lombardo, D., and Mas, E. Rs488087 single nucleotide
polymorphism as predictive risk factor for pancreatic cancers. Oncotarget. 2015;
Martinez,S., Scerbo, P., Giordano, M., Daulat, A. M., Lhoumeau, A. C., Thome, V.,
Kodjabachian, L., and Borg, J. P. The PTK7 and ROR2 receptors interact in the vertebrate
WNT/PCP pathway. Journal of Biological Chemistry. 2015;
Mathison,A., Escande, C., Calvo, E., Seo, S., White, T., Salmoson, A., Faubion, W. A., Jr.,
Buttar, N., Iovanna, J., Lomberk, G., Chini, E. N., and Urrutia, R. Phenotypic Characterization
of Mice Carrying Homozygous Deletion of KLF11, a Gene in which Mutations Cause Human Neonatal
and MODY VII Diabetes. Endocrinology. 2015; 56:3581-3595.
McCauley,H.A. and Guasch, G. Three cheers for the goblet cell: maintaining homeostasis in
mucosal epithelia. Trends Mol Med. 2015; 21:492-503.
Unité de Recherche. Centre de Recherche en Cancérologie de Marseille (CRCM)
Mis à jour : janvier 2017
34/38
Meguenani,M., Miljkovic-Licina, M., Fagiani, E., Ropraz, P., Hammel, P., Aurrand-Lions,
M., Adams, R. H., Christofori, G., Imhof, B. A., and Garrido-Urbani, S. Junctional adhesion
molecule B interferes with angiogenic VEGF/VEGFR2 signaling. FASEB J. 2015; 29:3411-3425.
Meni,C., Bruneau, J., Georgin-Lavialle, S., Le Sache de Peufeilhoux L., Damaj, G., HadjRabia, S., Fraitag, S., Dubreuil, P., Hermine, O., and Bodemer, C. Paediatric mastocytosis: a
systematic review of 1747 cases. Br J Dermatol. 2015; 172:642-651.
Molejon,M.I. and Iovanna, J. L. IER3 in pancreatic carcinogenesis. Oncotarget. 2015; 6:1571215713.
Molejon,M.I., Tellechea, J. I., Moutardier, V., Gasmi, M., Ouaissi, M., Turrini, O., Delpero,
J. R., Dusetti, N., and Iovanna, J. Targeting CD44 as a novel therapeutic approach for treating
pancreatic cancer recurrence. Oncoscience. 2015; 2:572-575.
Molejon,M.I., Tellechea, J. I., Loncle, C., Gayet, O., Gilabert, M., Duconseil, P., LopezMillan, M. B., Moutardier, V., Gasmi, M., Garcia, S., Turrini, O., Ouaissi, M., Poizat, F.,
Dusetti, N., and Iovanna, J. Deciphering the cellular source of tumor relapse identifies CD44 as a
major therapeutic target in pancreatic adenocarcinoma. Oncotarget. 2015; 6:7408-7423.
Morgand,M., Bouvin-Pley, M., Plantier, J. C., Moreau, A., Alessandri, E., Simon, F., Pace, C.
S., Pancera, M., Ho, D. D., Poignard, P., Bjorkman, P. J., Mouquet, H., Nussenzweig, M. C.,
Kwong, P. D., Baty, D., Chames, P., Braibant, M., and Barin, F. A V1V2 neutralizing epitope is
conserved in divergent non-M groups of HIV-1. J Acquir Immune Defic Syndr. 2015;
Morin,S.O., Giroux, V., Favre, C., Bechah, Y., Auphan-Anezin, N., Roncagalli, R., Mege, J.
L., Olive, D., Malissen, M., and Nunes, J. A. In the absence of its cytosolic domain, the CD28
molecule still contributes to T cell activation. Cell Mol Life Sci. 2015; 72:2739-2748.
Moris,M.A., Andrieu, C., Rocchi, P., Seillan, C., Acunzo, J., Brunel, F., Garzino, F., Siri, O.,
and Camplo, M. 2,3-Dialkoxyphenazines as anticancer agents. Tetrahedron Lett. 2015; 56:26952698.
Mourgues,L., Imbert, V., Nebout, M., Colosetti, P., Neffati, Z., Lagadec, P., Verhoeyen, E.,
Peng, C., Duprez, E., Legros, L., Rochet, N., Maguer-Satta, V., Nicolini, F. E., Mary, D., and
Peyron, J. F. The BMI1 polycomb protein represses CyclinG2-induced autophagy to support
proliferation in Chronic Myeloid Leukemia cells. Leukemia. 2015; 29:1993-2002.
Navarro,J.M., Touzart, A., Pradel, L. C., Loosveld, M., Koubi, M., Fenouil, R., Le Noir S.,
Maqbool, M. A., Morgado, E., Gregoire, C., Jaeger, S., Mamessier, E., Pignon, C., HaceinBey-Abina, S., Malissen, B., Gut, M., Gut, I. G., Dombret, H., Macintyre, E. A., Howe, S. J.,
Gaspar, H. B., Thrasher, A. J., Ifrah, N., Payet-Bornet, D., Duprez, E., Andrau, J. C.,
Asnafi, V., and Nadel, B. Site- and allele-specific polycomb dysregulation in T-cell leukaemia. Nat
Commun. 2015; 6:6094Nevoltris,D., Lombard, B., Dupuis, E., Mathis, G., Chames, P., and Baty, D. Conformational
Nanobodies Reveal Tethered Epidermal Growth Factor Receptor Involved in EGFR/ErbB2 Predimers.
ACS.Nano. 2015; 9:1388-1399.
Ochsenbein,F., Morelli, X., and Verma, C. Editorial. Prog Biophys Mol Biol. 2015; 119:1Olivares,O. and Vasseur, S. Metabolic rewiring of pancreatic ductal adenocarcinoma: New routes
to follow within the maze. Int J Cancer. 2015;
Pangon,L., Mladenova, D., Watkins, L., Van Kralingen, C., Currey, N., Al-Sohaily, S.,
Lecine, P., Borg, J. P., and Kohonen-Corish, M. R. MCC inhibits beta-catenin transcriptional
activity by sequestering DBC1 in the cytoplasm. Int J Cancer. 2015; 136:55-64.
Pasero,C., Gravis, G., Granjeaud, S., Guerin, M., Thomassin-Piana, J., Rocchi, P., Salem,
N., Walz, J., Moretta, A., and Olive, D. Highly effective NK cells are associated with good
prognosis in patients with metastatic prostate cancer. Oncotarget. 2015; 6:14360-14373.
Unité de Recherche. Centre de Recherche en Cancérologie de Marseille (CRCM)
Mis à jour : janvier 2017
35/38
Pasqualon,T., Pruessmeyer, J., Weidenfeld, S., Babendreyer, A., Groth, E., Schumacher,
J., Schwarz, N., Denecke, B., Jahr, H., Zimmermann, P., Dreymueller, D., and Ludwig, A. A
transmembrane C-terminal fragment of syndecan-1 is generated by the metalloproteinase ADAM17
and promotes lung epithelial tumor cell migration and lung metastasis formation. Cell Mol Life Sci.
2015; 72:3783-3801.
Pedrola,N., Devis, L., Llaurado, M., Campoy, I., Martinez-Garcia, E., Garcia, M., MuineloRomay, L., Alonso-Alconada, L., Abal, M., Alameda, F., Mancebo, G., Carreras, R.,
Castellvi, J., Cabrera, S., Gil-Moreno, A., Matias-Guiu, X., Iovanna, J. L., Colas, E.,
Reventos, J., and Ruiz, A. Nidogen 1 and Nuclear Protein 1: novel targets of ETV5 transcription
factor involved in endometrial cancer invasion. Clin Exp Metastasis. 2015; 32:467-478.
Peña,D., Rovetta, A. I., Hernandez Del Pino, R. E., Amiano, N. O., Pasquinelli, V.,
Pellegrini, J. M., Tateosian, N. L., Rolandelli, A., Gutierrez, M., Musella, R. M., Palmero, D.
J., Gherardi, M. M., Iovanna, J., Chuluyan, H. E., and Garcia, V. E. A Mycobacterium
tuberculosis Dormancy Antigen Differentiates Latently Infected Bacillus Calmette–Guérinvaccinated Individuals. EBioMedicine. 2015; 2:882-888.
Pical-Izard,C., Crocchiolo, R., Granjeaud, S., Kochbati, E., Just-Landi, S., Chabannon, C.,
Frassati, C., Picard, C., Blaise, D., Olive, D., and Fauriat, C. Reconstitution of Natural Killer
Cells In HLA-Matched HSCT after Reduced Intensity Conditioning. Impact on clinical outcome. Biol
Blood Marrow Transplant. 2015; 21:429-439.
Poggi,M., Morin, S. O., Bastelica, D., Govers, R., Canault, M., Bernot, D., Georgelin, O.,
Verdier, M., Burcelin, R., Olive, D., Alessi, M. C., Peiretti, F., and Nunes, J. A. CD28 deletion
improves obesity-induced liver steatosis but increases adiposity in mice. Int J Obes.(Lond.). 2015;
39:977-985.
Prantner,A.M., Turini, M., Kerfelec, B., Joshi, S., Baty, D., Chames, P., and Scholler, N.
Anti-Mesothelin Nanobodies for Both Conventional and Nanoparticle-Based Biomedical Applications.
J Biomed Nanotechnol. 2015; 11:1201-1212.
Puvirajesinghe,T.M. and Borg, J. P. Neural tube defects: from a proteomic standpoint.
Metabolites. 2015; 5:164-183.
Qin,Z., Zhou, X., Pandey, N. R., Vecchiarelli, H. A., Stewart, C. A., Zhang, X., Lagace, D. C.,
Brunel, J. M., Beique, J. C., Stewart, A. F., Hill, M. N., and Chen, H. H. Chronic Stress Induces
Anxiety via an Amygdalar Intracellular Cascade that Impairs Endocannabinoid Signaling. Neuron.
2015; 85:1319-1331.
Qin,Z., Pandey, N. R., Zhou, X., Stewart, C. A., Hari, A., Huang, H., Stewart, A. F., Brunel,
J. M., and Chen, H. H. Functional properties of Claramine: a novel PTP1B inhibitor and insulinmimetic compound. Biochem Biophys Res Commun. 2015; 458:21-27.
Remo,A., Simeone, I., Pancione, M., Parcesepe, P., Finetti, P., Cerulo, L., Bensmail, H.,
Birnbaum, D., Van Laere, S. J., Colantuoni, V., Bonetti, F., Bertucci, F., Manfrin, E., and
Ceccarelli, M. Systems biology analysis reveals NFAT5 as a novel biomarker and master regulator
of inflammatory breast. J Transl Med. 2015; 13:138Roucourt,B., Meeussen, S., Bao, J., Zimmermann, P., and David, G. Heparanase activates the
syndecan-syntenin-ALIX exosome pathway. Cell Res. 2015; 25:412-428.
Rousserie,G., Grinevich, R., Brazhnik, K., Even-Desrumeaux, K., Reveil, B., Tabary, T.,
Chames, P., Baty, D., Cohen, J. H. M., Nabiev, I., and Sukhanova, A. Detection of
carcinoembryonic antigen using single-domain or full-size antibodies stained with the quantum dot
conjugates. Anal Biochem. 2015; 478:26-32.
Roy,S., de Melo, A. J., Xu, Y., Tadi, S. K., Negrel, A., Hendrickson, E., Modesti, M., and
Meek, K. XRCC4/XLF interaction is variably required for DNA repair, and is not required for Ligase
IV stimulation. Mol Cell Biol. 2015; 35:3017-3028.
Saadi,H., Seillier, M., and Carrier, A. The stress protein TP53INP1 plays a tumor suppressive
role by regulating metabolic homeostasis. Biochimie. 2015; 118:44-55.
Unité de Recherche. Centre de Recherche en Cancérologie de Marseille (CRCM)
Mis à jour : janvier 2017
36/38
Sabatier,R., Finetti, P., Mamessier, E., Adelaide, J., Chaffanet, M., Ali, H. R., Viens, P.,
Caldas, C., Birnbaum, D., and Bertucci, F. Prognostic and predictive value of PDL1 expression in
breast cancer. Oncotarget. 2015; 6:5449-5464.
Saland,E., Boutzen, H., Castellano, R., Pouyet, L., Griessinger, E., Larrue, C., de Toni F.,
Scotland, S., David, M., Danet-Desnoyers, G., Vergez, F., Barreira, Y., Collette, Y., Recher,
C., and Sarry, J. E. A robust and rapid xenograft model to assess efficacy of chemotherapeutic
agents for human acute myeloid leukemia. Blood Cancer J. 2015; 5:e297Salazar,M., Lorente, M., Garcia-Taboada, E., Perez Gomez, E., Davila, D., Zuniga-Garcia,
P., Maria Flores, J., Rodriguez, A., Hegedus, Z., Mosen-Ansorena, D., Aransay, A. M.,
Hernandez-Tiedra, S., Lopez-Valero, I., Quintanilla, M., Sanchez, C., Iovanna, J. L.,
Dusetti, N., Guzman, M., Francis, S. E., Carracedo, A., Kiss-Toth, E., and Velasco, G. Loss of
Tribbles pseudokinase-3 promotes Akt-driven tumorigenesis via FOXO inactivation. Cell Death
Differ. 2015; 22:131-144.
Santhanam,P., Solnes, L., Hannukainen, J. C., and Taieb, D. Adiposity-related cancer and
functional imaging of brown adipose tissue. Endocr Pract. 2015; 21:1282-1290.
Secq,V., Leca, J., Bressy, C., Guillaumond, F., Skrobuk, P., Nigri, J., Lac, S., Lavaut, M. N.,
Bui, T. T., Thakur, A. K., Callizot, N., Steinschneider, R., Berthezene, P., Dusetti, N.,
Ouaissi, M., Moutardier, V., Calvo, E., Bousquet, C., Garcia, S., Bidaut, G., Vasseur, S.,
Iovanna, J. L., and Tomasini, R. Stromal SLIT2 impacts on pancreatic cancer-associated neural
remodeling. Cell Death Dis. 2015; 6:e1592Seillier,M., Pouyet, L., N'Guessan, P., Nollet, M., Capo, F., Guillaumond, F., Peyta, L.,
Dumas, J. F., Varrault, A., Bertrand, G., Bonnafous, S., Tran, A., Meur, G., Marchetti, P.,
Ravier, M. A., Dalle, S., Gual, P., Muller, D., Rutter, G. A., Servais, S., Iovanna, J. L., and
Carrier, A. Defects in mitophagy promote redox-driven metabolic syndrome in the absence of
TP53INP1. EMBO Mol Med. 2015; 7:802-818.
Serge,A., Bailly, A. L., Aurrand-Lions, M., Imhof, B. A., and Irla, M. For3D: Full Organ
Reconstruction in 3D, an Automatized Tool for Deciphering the Complexity of Lymphoid Organs. J
Immunol Methods. 2015; 424:32-42.
Siernicka,M., Winiarska, M., Bajor, M., Firczuk, M., Muchowicz, A., Bobrowicz, M., Fauriat,
C., Golab, J., Olive, D., and Zagozdzon, R. Adenanthin, a new inhibitor of thiol-dependent
antioxidant enzymes, impairs the effector functions of human natural killer cells. Immunology.
2015; 146:173-183.
Soucie,E., Brenet, F., and Dubreuil, P. Molecular basis of mast cell disease. Mol Immunol. 2015;
63:55-60.
Sperandio,O., Villoutreix, B. O., Morelli, X., and Roche, P. Chemical libraries dedicated to
protein-protein interactions. Med Sci (Paris). 2015; 31:312-319.
Taieb,D., Garrigue, P., Bardies, M., Abdullah, A. E., and Pacak, K. Application and Dosimetric
Requirements for Gallium-68-labeled Somatostatin Analogues in Targeted Radionuclide Therapy for
Gastroenteropancreatic Neuroendocrine Tumors. PET Clin. 2015; 10:477-486.
Taieb,D., Barlier, A., Yang, C., Pertuit, M., Tchoghandjian, A., Rochette, C., ZattaraCanoni, H., Figarella-Branger, D., Zhuang, Z., Pacak, K., and Metellus, P. Somatic gain-offunction HIF2A mutations in sporadic central nervous system hemangioblastomas. J Neurooncol.
2015;
Tanou,G., Minas, I. S., Karagiannis, E., Tsikou, D., Audebert, S., Papadopoulou, K. K., and
Molassiotis, A. The impact of sodium nitroprusside and ozone in kiwifruit ripening physiology: a
combined gene and protein expression profiling approach. Ann Bot. 2015; 116:649-662.
Thomas,E., Sircaik, S., Roman, E., Brunel, J. M., Johri, A. K., Pla, J., and Panwar, S. L. The
activity of RTA2, a downstream effector of the calcineurin pathway, is required during tunicamycininduced ER stress response in Candida albicans. FEMS Yeast Res. 2015;
Unité de Recherche. Centre de Recherche en Cancérologie de Marseille (CRCM)
Mis à jour : janvier 2017
37/38
Tiberi,G., Pekowska, A., Oudin, C., Ivey, A., Autret, A., Prebet, T., Koubi, M., Lembo, F.,
Mozziconacci, M. J., Bidaut, G., Chabannon, C., Grimwade, D., Vey, N., Spicuglia, S.,
Calmels, B., and Duprez, E. PcG methylation of the HIST1 cluster defines an epigenetic marker
of acute myeloid leukemia. Leukemia. 2015; 29:1202-1206.
Tichet,M., Prod'Homme, V., Fenouille, N., Ambrosetti, D., Mallavialle, A., Cerezo, M.,
Ohanna, M., Audebert, S., Rocchi, S., Giacchero, D., Boukari, F., Allegra, M., Chambard, J.
C., Lacour, J. P., Michiels, J. F., Borg, J. P., Deckert, M., and Tartare-Deckert, S. Tumourderived SPARC drives vascular permeability and extravasation through endothelial VCAM1
signalling to promote metastasis. Nat Commun. 2015; 6:6993Tomaszowski,K.H., Aasland, D., Margison, G. P., Williams, E., Pinder, S. I., Modesti, M.,
Fuchs, R. P., and Bernd, K. The bacterial alkyltransferase-like (eATL) protein protects
mammalian cells against methylating agent-induced toxicity. DNA Repair.(Amst.). 2015; 28C:1420.
Toubiana,J., Rossi, A. L., Belaidouni, N., Grimaldi, D., Pene, F., Chafey, P., Comba, B.,
Camoin, L., Bismuth, G., Claessens, Y. E., Mira, J. P., and Chiche, J. D. Src-family-tyrosine
kinase Lyn is critical for TLR2-mediated NF-kappaB activation through the PI 3-kinase signaling
pathway. Innate Immun. 2015; 21:685-697.
Ugalde-Olano,A., Egia, A., Fernandez-Ruiz, S., Loizaga-Iriarte, A., Zuñiga-Garcia, P.,
Garcia, S., Royo, F., Lacasa-Viscasillas, I., Castro, E., Zabala-Letona, Martin-Martin, N.,
Arruabarrena-Aristorena, A., Torrano-Moya, V., Valcarcel-Jimenez, L., SanchezMosquera, P., Caro-Maldonado, A., Gonzalez-Tampan, J., Cachi-Fuentes, G., Bilbao, E.,
Montero, R., Fernandez, S., Arrieta, E., Zorroza, K., Castillo-Martin, M., Serra, V., Salazar,
EI., Macias-Camara, N., Tabernero, J., Baselga, J., Cordon-Cardo, C., Aransay, A. M., Del
Villar, A., Iovanna, J. L., Falcon-Perez, J. M., Unda, M., Bilbao, R., and Carracedo, A.
Methodological aspects of the molecular and histological study of prostate cancer: Focus on PTEN.
Methods. 2015; 77-78:25-30.
Vasseur,S. and Guillaumond, F. L'adénocarcinome pancréatique : une tumeur dépendante des
lipoprotéines. Med Sci (Paris). 2015; 31:728-730.
Vasseur,S. and Manie, S. N. ER stress and Hexosamine Pathway during tumourigenesis: a pas de
deux? Semin Cancer Biol. 2015; 33:34-39.
Vincentelli,R., Luck, K., Poirson, J., Polanowska, J., Abdat, J., Blemont, M., Turchetto, J.,
Iv, F., Ricquier, K., Straub, M. L., Forster, A., Cassonnet, P., Borg, J. P., Jacob, Y., Masson,
M., Nomine, Y., Reboul, J., Wolff, N., Charbonnier, S., and Trave, G. Quantifying domainligand affinities and specificities by high-throughput holdup assay. Nat Methods. 2015; 12:787793.
Vlijm,R., Mashaghi, A., Bernard, S., Modesti, M., and Dekker, C. Experimental phase diagram
of negatively supercoiled DNA measured by magnetic tweezers and fluorescence. Nanoscale. 2015;
7:3205-3216.
Wei,T., Chen, C., Liu, J., Liu, C., Posocco, P., Liu, X., Cheng, Q., Huo, S., Liang, Z.,
Fermeglia, M., Pricl, S., Liang, X. J., Rocchi, P., and Peng, L. Anticancer drug nanomicelles
formed by self-assembling amphiphilic dendrimer to combat cancer drug resistance. Proc Natl Acad
Sci U S A. 2015; 112:2978-2983.
Weis,S., Bielow, T., Sommerer, I., Iovanna, J., Malicet, C., Mössner, J., and Hoffmeister,
A. P8 deficiency increases cellular ROS and induces HO-1. Arch Biochem Biophys. 2015; 565:8994.
Xie,C.M., Wei, D., Zhao, L., Marchetto, S., Mei, L., Borg, J. P., and Sun, Y. Erbin is a novel
substrate of the Sag-betaTrCP E3 ligase that regulates KrasG12D-induced skin tumorigenesis. J
Cell Biol. 2015; 209:721-738.
Zemmour,C., Bertucci, F., Finetti, P., Chetrit, B., Birnbaum, D., Filleron, T., and Boher, J.
M. Prediction of early breast cancer metastasis from DNA microarray data using high-dimensional
cox regression models. Cancer Inform. 2015; 14:129-138.
Unité de Recherche. Centre de Recherche en Cancérologie de Marseille (CRCM)
Mis à jour : janvier 2017
38/38